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Ratio of calcium and creatinine in random urine of Korean children.
H.O. Roh and J.S. Lee, Department of Pediatrics, Yonsei University,
College of Medicine, Seoul, Korea. Hypercalciuria must be diagnosed
early and treated adequately, since it is an important cause of hematuria
and ureter stones, and also because it may damage the renal tubules
irreversibly and decrease the concentration ability of urine. Until now
in Korea, there has been only a small number of reports and no useful
standards on calciuria. Our study was done to find the normal value of
the ratio of calcium and creatinine in random urine of Korean children.
We studied 464 children in the pediatric department of the Yonsei
University Hospital who had normal serum calcium levels and no renal
and endocrine disease or calcium metabolic abnormalities. Urine col-
lection was done using a disposable urine collector for children under 3
years of age, and a urine cup for children over 3 years of age. Urine
sodium, creatinine and calcium were evaluated. Analysis was done by
PC-SPSS to assess the mean SD of each age, and the differences of
each group were compared using a 1-test. The results were as follows:
Ca/Cr ratio was 0.05 0.09 (mean SD mg/dl) in 0—7 days, 0.28 0.24
in 8—30 days, 0.22 0.21 in 1—Il months, 0.20 0.19 in 1—5 years, 0.17
0.l9in6—ll yearsand0.12 0.O9in 12—lsyearsgroups. Comparing
ratios in each age group, 0—7 days and 12—15 years groups showed a
difference compared to other groups (P < 0.05). In conclusion, the
Ca/cr ratio in random urine of Korean children showed a difference
between the 0—7 days, 12—15 years and other age groups. The normal
value of 0—7 days group is 0.05 0.09, and 12—15 years group is 0.12
0.09. The other groups were 0.20 0,21 mg/dl.
Bone mineral density in children wIth idiopathic hypercalciuria. C. W.
Ko and J.H. Koo, Department of Pediatrics, Kyungpook National
University School of Medicine, Taegu, Korea. Idiopathic hypercalci-
uria (IH) is one of the major causes of childhood hematuria, and its
pathogenesis is not exactly known yet, but negative calcium balance is
frequent. A prospective study was conducted to determine the presence
and degree of change of bone mineral density in children with IH. Study
patients consisted of 18 children with IH (24 hour urinary calcium = 5.9
2.2 mg/kg/day), and the control group consisted of 18 normocalciuric
children. Vertebral mineral density was measured in each patient by
single energy quantitative computer tomography (QCT), and the fol-
lowing results of average vertebral mineral density (mg/cc) were ob-
tained:
Absorptive IH(N = 11)
Renal IH(N = 7)
Control
(N = 18)
161.5 211b 170.6 l6,2a 183.7 12.8
(155.1—199.8) (154.4—195.1) (165.1—216.8)
a p < oo5, "P < 0.01 compared to control
These results suggest that both absorptive and renal type hypercalciuric
children, when compared to normocalciuric children, have significantly
lower bone mineral content, so we think that calcium restriction for the
treatment of hypercalciuria in growing children should be reconsidered.
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Anomalies associated with perinatal deaths based on autopsy: Focused
mainly on urinary tract anomalies. K. T. Sung, J.B. Yoon, and H.K.
Yoon, Departments of Urology and Pathology, Pusan National Uni-
versity Hospital, Inje University Hospital, Pusan, Korea. We reviewed
the records of 301 fetuses and neonates autopsied due to perinatal
deaths during the period from 1986 to 1991. Thirty-eight cases with
urinary tract anomalies were examined with their associated anomalies
in other organs and compared with their relationships to the volume of
amniotic fluid. (1). Of 38 kidneys with congenital developmental distur-
bances in 24 cases of renal abnomalies, 14 (36.8%) were dysplastic, 10
(26.3%) were hypoplastic, 7 (18.4%) were aplastic, 4 (10.5%) were
polycystic, 3 (7.9%) were hyperplastic, and 3 were horseshoe kidney.
(2). Of 12 cases with lower urogenital anomalies, 5 were exstrophy of
bladder, 3 were posterior urethral valve, 3 were vesicorectal fistula, and
1 prune-belly syndrome. (3). Of 32 cases of associated respiratory
anomalies, pulmonary dysplasia was most common with 19 cases
(55.9%). Of 16 cases with gastrointestinal anomalies, imperforated anus
was most common with 6 cases (37.5%). Of cardiovascular anomalies,
congenital heart disease was in 6 (66.7%) and a single umbilical artery
in 3 (33.3%). Of 5 cases with CNS anomalies, hydrocephalus was in 2
(40%), anencephaly in 1, spina bifida in 1, and sacrococcygeal teratoma
in 1 (20%). Of 13 cases with adrenal anomalies, congestion and
hemorrhage in adrenal medulla was most common with 4 cases (30.8%).
Other anomalies are fetal hydrops in 4 (66.7%) and congenital syphilis
in 2 (33.3%). (4). Of 28 cases with pre-estimated volume of amniotic
fluid, S were either bilateral renal dysplasia, bilateral or unilateral renal
agenesis with associated pulmonary hypoplasia in all, whereas in 7
cases of lower urinary tract anomalies with hydronephrosis and oligo-
hydroamnios 4 were associated pulmonary hypoplasia. Of 13 cases with
other renal and lower urinary tract anomalies, 4 were associated with
oligohydroamnios and 9 with polyhydroamnios. Of 9 cases with poly-
hydroamnios, 3 were associated with pulmonary hypoplasia. It is
shown that oligohydroamnios is associated mostly with pulmonary
hypoplasia, whereas in polyhydroamnios, pulmonary hypoplasia is
infrequently associated.
Renal tubular acidosis induced by cadmium. D.W. Ahn, K.R. Kim,
C.K. Choi, J.S. Kim, and Y.S. Park, Department of Physiology, Kosin
Medical College, Pusan, Korea. Renal acid-base regulation was studied
in rats (Sprague-Dawley) intoxicated by cadmium. Cadmium intoxica-
tion was induced by subcutaneous injections of CdCl2 at a dose of 2
mg/kg day for 3—4 weeks. In cadmium-intoxicated animals, arterial
pH, PCO2 and bicarbonate concentration decreased, indicating that
metabolic acidosis was developed. Urine pH and urinary bicarbonate
excretion increased and titratable acid excretion decreased with no
significant change in ammonium output. The rise in bicarbonate excre-
tion was associated with a reduction of renal tubular Tm for bicarbon-
ate. In renal cortical brush border membrane vesicles isolated from
cadmium intoxicated animals, the Na-H antiporter activity appeared
to be significantly attenuated. These results indicate that chronic
exposure to cadmium impairs the proximal tubular mechanism for H
secretion (that is, Na-H antiport), leading to a metabolic acidosis of
typical proximal type RTA.
Acid-base and electrolytes changes in blood and urine after artificially
induced acute diarrhea by laxatives. H.J. Kim, C.H. Park, C.M. Kang,
H.C. Park, and K.N. Park, Divisions of Nephrology and Gastroenler-
ology, Department of Internal Medicine, Hanyang University Hospital,
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Seoul, Korea. The acute diarrhea in patients admitted to GI service
without active diarrhea (N = 24) was induced overnight by commonly
used laxatives (that is, castor oil and bisacodyl) for bowel preparation.
Following it, the changes of electrolytes and acid-base balances in
blood and urine were investigated, and simultaneously, the measure-
ments of urinary ammonium and anion gap equal to (Na + K — C1)
were performed to see any contribution to those changes. Though the
alterations of serum sodium and potassium were not noted, mild but
significant reduction of mean values (±sEM) of plasma pH and HC03
after diarrhea when compared to those before it were developed (pH; from
7.42 0.01 to 7.39 0.01, P < 0.01, HC03; from 25.8 0.6 to 23.7
0.6 mEq/liter, P < 0.05). However, significant reductions in sodium from
150 12.3 to 93 14 mEq/liter (P < 0.01) but increases of potassium from
33 3.2 to 51 6.0 mEqIL (P < 0.05) in urinary excretion following
diarrhea were seen with significant reduction of urine pH from 6.67 0.21
to 5.5 0.13 (P < 0.001). Also, to these effective urinary acidifications
following diarrhea, the significant reductions of urinary anion gap as well
as significant increments of urinary ammonium were accompanied (anion
gap; from 80.4 11.1 to 44 8.5 mEq/liter, P < 0,001, ammonium; from
87 18.5 to 229 37 mg/dl, P < 0.001). The significant correlation
between changes of these two variables from baseline values before
diarrhea was seen (r = 0.74; P < 0.001). In conclusion, the effective
urinary acidification with hyperexcretion of ammonium functioned well to
mitigate the acute change of blood pH in extra-renal acidosis evoked by
acute diarrhea, and urinary anion gap was confirmed again as an indirect
marker of urinary ammonium.
Clinical effects of aspiration-sclerotherapy of renal cysts with minocy-
dine hydrochloride. S.S. Oh, Department of Urology, College of
Medicine, Dong A University, Pusan, Korea. As a nonsurgical proce-
dure for the treatment of renal cysts, various scierosing agents are used
and, especially, 95% ethyl alcohol has recently been favored for
aspiration-sclerotherapy of renal cysts. However, there is an inconve-
nience of 95% ethyl alcohol, which has to be drained after installation,
whereas with minocycline hydrochloride no drainage is needed. We
have treated 46 cases of simple renal cysts (43 cases of single renal cysts
and 3 cases of multiple renal cysts) and 5 cases of polycystic kidney
with minocycline hydrochloride 200mg in 2cc mixed with normal saline
after aspiration of renal cysts, from July 1990 to December 1992. The
cyst diameter ranged from 2.2 cm to 12.0cm with a mean of 4.72 cm.
The follow-up period varied from 3 to 12 months with an average of 5.8
months. Single procedure was satisfactory in 47 cases and two proce-
dures in 4 cases. At the third month of follow-up, renal cysts were
ablated in 20 cases, cyst diameter reduced more than 90% was in 1 case,
and cyst diameter reduced more than 50% was in 19 cases. In all, cyst
diameter was reduced more than 50% in 40 cases. There were 1 case of
ecchymosis and 7 cases of flank pain of which 3 were managed with
analgesics. Therefore, we believe aspiration-sclerotherapy with mi-
nocycline hydrochloride for the treatment of renal cysts is a simple and
effective procedure with minimal sequlae.
Role of kidney and liver in the renotropic activity after uninephrectomy
in rats. Y.S. Kim and B.K. Bang, Department of Internal Medicine,
Catholic University Medical College, Seoul, Korea. Following unine-
phrectomy (UNx), the remnant kidney undergoes a compensatory
growth apparently regulated by a humoral renotropic factor. To assess
whether the kidney is the source of the renotropic activity and the liver is
concerned in the renotropic activity generated after UNx, the [3Hlthymi-
dine incorporation into tubule DNA was observed when the extracts of rat
kidney obtained at 6 hours, 24 hours and 48 hours after UNx was assayed
in cortical tubules from rat kidney removed 24 hours after UNx.
Effect of UNx kidney extracts on tubule DNA synthesis
Dilution
(-fold) 10 102 io io
6 hr UNx 109.2 10.4 114.7 5,4a 154.8 14.7a 101.4 6.2
24 hr UNx 128.8 6.5 123.7 16.0 105.9 16.6 111.0 2.0
48 hr UNx 98.0 13.0 97.0 7.4 108.0 4.8 104.0 14.0
Values are [3H]thymidine incorporation (% of sham values, mean SD)a P < 0.05 vs. sham value
The activity displayed by the kidney extracts from 6 hours or 24 hours
after UNx was abolished in extracts of perfused kidneys with saline or
when partial hepatectomy was performed simultaneously with UNx.
The undiluted plasma obtained from 6 hours or 24 hours UNx rats
before organ perfusion and removal tended to induce tubule DNA
synthesis over that observed with plasma of sham operated rats: 149.8
48.1%, from 6 hour UNx rats, 132 14.0% from 24 hour UNx rats,
but not at dilutions matching those of the kidney extracts. In conclu-
sion, our results suggest that the circulating renotropic factor generated
after UNx has an extrarenal origin, although the kidney might play a
role in the regulation of its activity. The liver could play a role in the
formation or the activation of the renotropic factor.
Clinical investigation of malignant hypertension in Korea. D.J. Oh,
C.H. Kim, J.S. Song, E.T. Kang, and S.H. Yu, Department of Internal
Medicine, College of Medicine, Chung-Ang University, Seoul, Korea.
Malignant hypertension has been used to define patients with grade 3 or
4 hypertensive retinopathy and characterized by rapidly increasing
blood pressure and declining renal function. Therefore, early recogni-
tion and adequate management are crucial for patient survival and
ensuring minimal damage to target organs. Lately, the development of
antihypertensive agents and the availability of dialysis influenced renal
survival, patient survival, and even the incidence of primary malignant
hypertension. However there have been no reports of maligt hyper-
tension in the 1990's and none reported in Korea so far. To know the
etiology and clinical course of malignant hypertension in Korea, we
retrospectively reviewed the patients with malignant hypertension who
visited our department between 1988 and 1992. One hundred seven
patients were enrolled.
Etiology
Male Female Age Initial BP
Primary 30 29 56 209 (150—300)/128 (100—180)
Secondary
Renal 19 16 37 194 (150—250)1120 (100—150)
Renovascular 2 0 45 210 (180—250)1130 (100—160)
Undetermined 9 2 41 183 (140—210)1125 (100—150)
Treatment modality
Medical Tx 72
Replacement Tx 35
HD 24
PD 4
Kidney transplantation 7
Survival rate
Renal survival 82% (1 yr) 51% (5 yr)
Patient survival 91% (1 yr) 78% (5 yr)
Patient survival rate in
accordance with initial
serum Cr
Initial creatinine < 3 97% (1 yr) 92% (5 yr)
mg%
Initial creatinine > 3 88% (1 yr) 81% (5 yr)
mg%
Patient survival rate in
accordance with etiology
Primary 90% (1 yr) 85% (5 yr)
Secondary 94% (1 yr) 86% (5 yr)
Cause of death
CVA 3
Hepatic coma I
Hyperkalemia 3
Lung cancer I
Pulmonary edema I
Socioeconomic factor 1
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Plasma endothelin concentration in hypertension. G.B. Choi, H.J.
Kim, G.J. Shin, W.H. Lee, and K.!. Yoon, Department of Internal
Medicine, Ewha Womans University Hospital, Seoul, Korea. Until now
there were debates about the cause of essential hypertension, but the
exact pathophysiology was not established. Endothelin was identified in
the cultured porcine aortic endothelial cell in 1988 and is a potent
vasoconstrictor peptide with 21 amino acids. Endothelin is secreted
from vascular endothelial cells. We measured and analyzed the endo-
thelin concentration in plasma and 24-hour urine by radioimmunoassay
in 16 patients with essential hypertension, 3 patients with secondary
hypertension, and 7 control groups. (1) There was no significant
difference in plasma endothelin levels between three groups (12.9
17.07, 2.3 0.34, 3.3 1,87 pg/mI). (2) Endothelin clearance of the
secondary hypertension group (46.6 13,54 mI/mm) was significantly
higher than in the essential hypertension group (5.2 6.16 mllmin) and
than in the control group (7.7 4.64mI/mm) (P < 0.05). There was no
significant difference in blood pressure between secondary and essential
hypertension groups. (3) Plasma endothelin concentration was posi-
tively correlated with diastolic blood pressure (r = 0.54, P < 0.05), but
was not correlated with systolic blood pressure in total cases, irrespec-
tive of group. (4) In the hypertensive group, there was no significant
difference in plasma endothelin concentration and endothelin clearance
between treated and untreated groups. In conclusion, it is hard to say
that endothelin has a primary pathophysiological role in hypertension.
Plasma endothelin concentration might be secondarily controlled by
diastolic pressure, but it will need further study.
Effects of anti-hypertensive treatment of angiotensin converting enzyme
inhibitor or calcium antagonist on the progression of glonieruloscierosis in
the excision remnant kidney model. K.S. Kim, E.J. Choi, S. Y. Kim, Y.J.
Kang, B.S. Kim, and W.J. Maeng, Department of Pediatrics and
Pathology, College of Medicine, and Department of Feed and Nutri-
tional Science, College of Animal Husbandry, KonKuk University,
Seoul, Korea. To investigate if blood pressure reduction may prevent
progressive renal disease in the remnant kidney excision model and to
compare antihypertensive drugs in rats having similar control of blood
pressure, a total of 41 Sprague-Dawley rats were treated with ACE
inhibitor, or calcium antagonist after 5/6 nephrectomy for 12 weeks. At
4 weeks and 12 weeks after surgery, systemic blood pressure, urinary
protein excretion and endogenous creatinine clearance were measured.
Histologic examination of kidney was performed and indices of glomer-
uloscierosis were determined. At 4 weeks after surgery, mean systolic
blood pressure of control rats was 153 mm Hg, enalapril-treated rats 137
mm Hg, and nicardipine-treated rats 149 mm Hg (P < 0.05). At 12
weeks, mean systolic blood pressure of control rats was 158 mm Hg,
enalapril-treated rats 119 mm Hg, and nicardipine-treated rats 120 mm
Hg (P < 0.05). 24 hour urine protein was not significantly different
among three groups at 4 weeks and 12 weeks after 5/6 nephrectomy.
Mean glomerular sclerosis at 4 weeks in control rats was 12%, enalapril-
treated rats 9%, and nicardipine-treated rats 13% (P < 0.05). Mean
glomerular sclerosis at 12 weeks in control rats was 25%, which was
higher than enalapril-treated rats and nicardipine-treated rats (16%,
20%, respectively; P < 0.01). Mean mesangial expansion score at 4
weeks in control rats was 20%, enalapril-treated rats 11%, and nicar-
dipine-treated rats 16% (P < 0.05). Mean mesangial expansion score at
12 weeks in control rats was 33%, which was higher than enalapril-
treated rats and nicardipine-treated rats (27%, 28%, respectively; P <
0.05). Blood urea nitrogen and serum lipid levels were not different
among three groups at 4 weeks and 12 weeks. These results illustrate
that the blood pressure reduction with ACE inhibitor or calcium
antagonist in the excision remnant kidney model is effective in prevent-
ing the progression of glomerulsclerosis.
Transport of organic compounds in renal plasma membrane vesicles of
post-ischemic rabbit kidney. Y.K. Kim, H.S. Byun, D.K. Jung, J.S.
Woo, and S.H. Lee, Department of Physiology, College of Medicine,
Pusan National University, Pusan, Korea. This study was undertaken
to determine the effect of renal ischemia on organic substance transport
in renal proximal tubular cells. Unilateral ischemia was induced by
clamping the left renal artery. The right kidney served as a paired
control. Following 30 or 60 minutes of ischemia, the fractional excretion
of glucose and phosphate markedly increased within the first 30 minutes
of reflow and remained above the control value by 3 hours of reflow.
However, Natdependent uptake of D-glucose, phosphate and succi-
nate by brush-border membrane vesicles (BBMV) was not altered by 30
or 60 minutes of ischemia, although it was significantly reduced by 120
minutes of ischemia. TEA/H'' antiport by BBMV was significantly
impaired by 30 minutes of ischemia and Na-dependent L-glutamate
uptake was not altered even after 120 minutes of ischemia. Na-
dependent D-glucose uptake by BBMV was not affected by 60 minutes
of reflow after ischemia. Na-dependent uptake of succinate and
L-glutamate by basolateral membrane vesicles (BLMV) from kidneys
subjected to 30—120 minutes of ischemia was not different from that of
control kidneys. The ouabain-sensitive oxygen consumption in cortical
slices and Na-K-ATPase activity in cortical microsome remained un-
impaired after 60 minutes of ischemia. These results suggest that
glucosuria and phosphaturia by a transient renal ischemia were due
neither to the direct impairment of the transport system itself for these
compounds nor a reduction in functional Na-pump activity in rabbit
renal proximal tubules.
Effect of thyroxine on cisplatin-induced nephrotoxicity. J.H. Ahn, J.O.
Kim, S.M. Shin, and Y.H. Park, Department of Pediatrics, School of
Medicine, Youngnam University, Taegu, Korea, This study was con-
ducted to test the hypothesis that thyroxine has a protective effect on
renal tubular injury induced by cisplatin. The changes in renal function,
electrolyte concentrations, renal cortical Na,K-ATPase activity and
alkaline phosphatase activities were measured in Sprague-Dawley rats
divided into four groups. Seven normal (THY) and 7 cisplatin treated
rats (CIS-THY) received thyroxine. Seven additional cisplatin treated
(CIS) and 11 normal control rats (NC) served as controls. Na,K-
ATPase activity (.&mole Pilmg protein/hr) was decreased in CIS (20.8
4.6) compared with NC group (31.4 5.2, P < 0.01). Contrarily, the
enzyme activity was increased in THY (42.9 3.0, P < 0.01) and
CIS-THY (41.7 7.7, P < 0.05) groups. ALPase activity (mole Pi/mg
protein/br) was decreased in CIS (2.6 0.8, P < 0.01) and thyroxine
treated THY (2.8 1.0, P < 0.05) and CIS-THY (3.1 0.9, P < 0.05)
compared with NC group (4.2 1.1). Nephrotoxicity was assessed by
measuring serum BUN, creatinine and electrolytes. Serum BUN (mg/
dl) and creatinine levels (mg/dl) were increased in CIS (144.2 44.4 and
5.0 2.7) compared with NC group (21.4 6.0 and 0.9 0.3, P <
0.01). However, serum BUN and creatinine levels were unchanged in
THY (18.1 2.7 and 0.7 0.1) and CIS-THY (18.7 3.8 and 0.7 0.1)
groups. The electrolytes were comparable in all four groups. Free
thyroxine level (ngldl) was decreased insignificantly in CIS (9.36 1.65)
but was increased in thyroxine treated THY (36.64 3.45) and
CIS-THY (30.55 7.32) compared with NC group (14.34 4.77, P <
0.01). These data indicate that thyroxine protects the kidney from
cisplatin-induced nephrotoxicity by enhancing renal cortical Na,K-
ATPase activity.
Differential gene expression as the recovery markers of acute renal
failure. D.R. Cha, Y.H. Lee, S.S. Kim, Y.J. Kwon, W. Y. Cho, and
H.K. Kim, Department of Internal Medicine, College of Medicine,
Korea University, Seoul, Korea. The severity of renal dysfunction after
acute renal failure depends on the extent of the initial renal damage as
well the pace of repair process, and the regeneration of tubular
epithelial cell is essential in the recovery of renal function. Recently,
several studies have revealed the importance of specific growth factors
such as epidermal growth factor (EGF) and transforming growth
factor-alpha (TGFa); the expression of these genes is increased during
the recovery stage of acute tubular necrosis. To evaluate the expression
of a wide variety of genes involved in cellular proliferation as well as
antioxidant protective mechanisms during acute ischemic renal failure,
authors made an acute ischemic renal failure model by rt nephrectomy
and left renal artery clamping for 40 minutes in 23 male Sprague-Dawiey
rats. The experimental animals were divided into three groups accord-
ing to the reperfusion time, and left nephrectomy was done after the
desired period of reperfusion (60 mm to 72 hr). Total renal RNA was
extracted by the acid guanidium thiocyanate/phenol chloroform extrac-
tion method, and Northern hybridization was performed using mouse
c-fos, rat superoxide dismutase (SOD), rat renin, rat EGF (epidermal
growth factor), and rat f3-actin as a probe. The results were as follows:
(1) c-fos gene was rapidly induced by renal ischemia with peak after 60
minutes of reflow, and 24 hours later c-fos message was markedly
decreased; (2) SOD expression was decreased early in the recovery
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phase and showed a substantial increase in activity 72 hours after
ischemia; (3) EGF gene expression was decreased after 1 hour of
reflow, and continuously suppressed thereafter; (4) Renin gene expres-
sion was markedly decreased early in the recovery phase, and a
substantially increased in activity after 24 hours reperfusion. From the
above findings, the selective and sequential gene expression after renal
ischemia might maximize the tubular regeneration, and these expres-
sions of a wide variety genes may play an important role in the recovery
phase of acute renal failure.
Neonatal sauna syndrome (syndrome of neonatal renal failure and
dermatologic disease caused by high temperature environment). K,S.
Pai, J.S. Lee, P.K. Kim, and M.J. Kim, Departments of Pediatrics and
Radiology, Yonsei University College of Medicine, Seoul, Korea.
There is a Korean custom of managing mother and baby after delivery
by keeping them in a hot room for 3 weeks. Under this hot environment,
neonates will have to suffer heat stress and this will lead to variable
dermatologic diseases as well as dehydration, sepsis, acute renal
failure, and even death. In order to study the incidence, type and
severity of the neonatal diseases of such an environment, we chose the
Okpo Hospital located in the southern part of the peninsula, where both
rural and urban areas coexist. All patients were neonates who came to
the hospital for vaccination or other medical cares. We studied for 12
months through questionnaires of post-delivery environments, physical
examination, blood chemistry, and imaging study. Among the total
1,953 neonates studied, 11 patients (0.56%) were severely dehydrated
and progressed to acute renal failure and electrolyte imbalance with
weight loss up to 25.8% of the birth weight; 10 of 11 patients (90.9%)
had increased BUN and creatinine; 5 patients (45.5%) had hyperna-
tremia (150—189 mEq/liter) and 4 patients (36.4%) had hyponatremia
(119—130 mEqlliter); 3 patients (27.3%) needed peritoneal dialysis.
Doppler pattern of the renal arteries showed decreased or negative
diastolic flows in renal failure patients. Dermatologic diseases such as
folliculitis, pustules, frunculosis, eczematous dermatitis and crusted
exfoliative dermatitis were observed in 113 neonates (5.8%), and 11
patients (0.56%) needed hospital admission. This custom is still popular
in rural rather than urban areas of Korea, which makes us feel that it is
important to educate families in rural areas about proper neonatal care
and investigate the epidemiology of this neonatal disease derived from
a hyperthermic environment. We propose that this kind of disease
entity of the neonates results from the unique Korean custom to have a
nomenclature of "Neonatal Sauna Syndrome" or "Neonatal Heat
Stress Syndrome."
Acute hypersensitivity Interstitial nephritis confirmed by renal biopsy.
5K. Rhee, S.S. Kim, M.S. Jeong, K.W. Lee, K.S. Seo, and Y.T. Shin,
Department of Internal Medicine and Pathology, College of Medicine,
Chungnam National University, Taejeon, Korea. Acute hypersensitiv-
ity interstitial nephritis is characterized by sudden renal dysfunction
associated with infiltration of inflammatory cells in renal interstitium
without glomerular and vascular lesions. We evaluated 7 patients with
acute hypersensitivity interstitial nephritis confirmed by renal biopsy at
Chungnam National University Hospital from January 1991 to Decem-
ber 1992. The results were as follows: Patients: Average age of patients
was 51.1 16.2 (range 30 to 76) years. Five patients were women.
Causative drugs: The suspected causes of acute hypersensitive intersti-
tial nephritis were NSAID, cephalosporin, ampicillin, gentamicin,
rifampin, ciprobay and herb medication. Laboratory findings: On uri-
nalysis, proteinuria occurred in all patients and hematuria and pyuria
occurred in 3 (43%) patients. The average serum level of BUN was 57.0
30.2 (range 19 to 107) mg/dl and that of serum creatinine was 6.2 3.3
(range 1.7 to 11.1) mg/dl. The reduction in GFR was observed in all
patients. Pathology: LM findings showed infiltration of monocytes,
lymphocytes and eosinophils in interstitium, interstitial edema and
tubular atrophy without evidence of significant glomerular lesions.
There was no definite evidence of immunoglobulin and complements in
IF study. EM showed infiltration of inflammatory cells in interstitium,
and there were no significant dense deposits. Clinical outcome: Patients
were treated with removal of the inciting agents, supportive care and
corticosteroids without hemodialysis. The serum creatinine levels were
normalized in 5 patients. However, two patients disclosed sustained
azotemia. Conclusion: We thought that acute hypersensitivity intersti-
tial nephritis should be considered as a cause of unexplained ARF.
U/A(/HPF)
No. Age Sex Causative drugs RBC WBX
1 59 F NSAID 0—1 1—2
2 58 M NSAID + Cephalosporin many 0—1
3 30 F NSAID + Ampicillin 0—1 2—3
4 76 F Herb medication 1—2 many
5 34 M NSAID + Ciprobay many many
6 58 F GM + Cephalosporin 3—5 many
7 43 F Rifampicin 0—1 0—1
Urine protein BUN Serum Cr
mg/day mg/dl mg/dl Eosinophilia Pathology
1775 34.4 3.2 + AIN
3100 19.0 1.7 + AIN
700 47.5 7.4 + AIN
1339 107.0 9.3 — AIN
869 81.0 11.1 — AIN
644 68.4 5.3 — AIN
232 42.0 5.3 — AIN
Abbreviation is AIN, acute interstitial nephritis.
Renal dysfunction and a case report of uremia in scrub typhus. H.J.
Kim, K.S. Lee, C.H. Park, C.M. Kang, and H.C. Park, Division of
Nephrology, Department of Internal Medicine, Hanyang University
Hospital, Seoul, Korea. The 239 cases of scrub typhus in Korea,
well-known as one of the widespread Asian zoonotic diseases, were
evaluated for the degree of azotemia and abnormal urinary findings, and
a very rare unrecognized uremic case report of scrub typhus requiring
hemodialysis was followed. Of 239 cases of scrub typhus, 218 were
already reported separately as eight groups by each different author
from 1984 through 1988, and 21 of newly diagnosed group from October
to November 1990 were added for this analysis. All cases were
confirmed by clinical and serological evidences with Rickettsia tsutsug-
amushi. Abnormal urinary findings were a mild to moderate degree of
proteinuria, microscopic hematuria and pyuria. The range of prevalence
(mean SEM, %) was 8—62% (26 6.3) in proteinuria, 0—43% (19 4.1)
in hematuria, and 0—44% (19 5.5) in pyuria. The prevalence of
azotemia (serum creatinine> 1.5—2.0 mg/dl or BUN > 20 mg/dl) in all
nine groups was from 0 to 38% (mean, 16 3.8%) and degree of
azotemia was very mild, no more than 3.5 mg/dl of serum creatinine in
most of the cases. However, in November 1992, a 74 year old farmer
admitted for scrub typhus with fever, eschar and positive serologic titer
by Weil-Felix reaction, as well as indirect immunofluorescent test
(IFA), showed uremic encephalopathy with BUN and creatinine 120
and 8.0 mg/dl. Following the hemodialysis as required and doxycyline
intake for the first 10 days in hospital, renal function improved and
BUN and creatinine were —21 and 1.5 mgldl on discharge of the 18th
hospital day. In conclusion, a mild degree of azotemia and abnormal
urinary findings with wide range of prevalence were noted in the
analysis of 239 cases in Korea. Also, though it was a single case, there
was no exception in the development of uremia due to acute renal
failure in scrub typhus.
Partial RNA sequences of hantavirus isolated from lUff patients. S.
Kim, C. Ahn, J.S. Han, K.W. Joo, G.H. Kim, J.T. Cho, 1.5. Kim, W.H.
Chang, and J.S. Lee, Department of Internal Medicine and Microbi-
ology, Seoul National University College of Medicine, Seoul, Korea.
The clinical severity of hantavirus infection is determined not only by
the host responses but also by the virulences of the infected viruses. In
order to evaluate the direct effect of virus to the host, we isolated
viruses from 90 body fluid samples obtained from 48 patients and 9
tissues from an autopsy case. The viral protein was identified by
indirect immunofluorescent method, Western blotting, and immunopre-
cipitation using monoclonal antibodies against the hantavirus, and the
genetic materials were identified using reverse transcriptase-PCR (RT-
PCR) and direct sequencing. (1) Hantaviruses were isolated from 42%
(20/48) of KHF patients and 34% (3 1/90) of body fluids. The culture
positivity of each body fluid was 75% (12/16) in blood, 30% (8/26) in
Table 1. Clinical characteristics
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plasma, 25% (3/12) in urine, 25% (2/8) in serum, and 18% (6/28) in
PBMC. (2) The viruses were isolated in 37% (30/81) of samples obtained
before day 9, and in 11% (1/9) of samples obtained after the 10th day of
illness. (3) Even though the viruses could be identified by indirect
immunofluorescent test, Western blotting or immunoprecipitation, it
was not possible to differentiate the viruses. (4) Amplified bands were
demonstrated after RT-PCR using universal primers in 21 cases, and by
direct sequencing method 11 different types of viruses were recognized.
Of these, 10 were Hantaan virus type and 1 was Seoul virus type. (5)
RNA sequences of these newly isolated viruses were compared with
those of prototype Hantavirus. The 10 Hantaan-type viruses showed
sequence homology of 90% or more and the Seoul-type virus 70%. In
conclusion, we isolated 11 different types of viruses from KHF patients
and confirmed them as Hantavirus. These human-isolated viruses may
play an important role in revealing the pathogenesis of KHF and be
used in developing vaccines against Hantavirus.
Development of monoclonal antibodIes to Hantaan virus. I.S. Ha, Y.
Choi, J.W. Koo, J.H. Park, H.W. Park, Y.S. Park, H.!. Cheong, !.S.
Kim, C. V. Cha, S. Kim, and J.S. Lee, Department of Pediatrics,
Microbiology, and Internal Medicine, Seoul National University Col-
lege of Medicine, Seoul, Korea. Diagnosis of hemorrhagic fever with
renal syndrome (HFRS) usually depends on detection of antibody in
patient's serum which may cross react with other viruses or serotypes.
We developed monoclonal antibodies to Hantaan virus that could be
useful as a research tool in this field, and also applicable clinically as a
diagnostic aid in identification of the virus and its serotype, BALB/c
mice were immunized intraperitoneally with partially purified Hantaan
virus isolated in Korea. The spleens were resected, and the spleen cells
were fused with P3-X63-Ag.V653 myeloma cells. Hybrid cells were
selected in HAT media, and antibody producing cells were identified by
indirect immunofluorescence (IF) method. By cloning through limiting
dilution, monoclones producing monoclonal antibodies were obtained.
The monoclonal antibodies were characterized concerning isotype,
titer, binding viral protein, and their reaction to other serotypes in
Hantavirus genus. Fifty-five monoclonal antibodies were obtained, 41
of IgG1, 10 of IgG2, 3 of IgA, 1 of 1gM isotype. Antibody titers ranged
from 1:4 to 1:1,024. Immunoblot assay and immunoprecipitation re-
vealed that all monoclonal antibodies bind to 48kDa nucleocapsid
protein. On indirect IF staining, 38 of the 55 monoclonal antibodies
reacted with Seoul viruses (SR-il, TCH, R-22) in addition to Hantaan
virus (76—i 18), of which fifteen also reacted with Prospect Hill virus.
None of them reacted with Puumala virus. The monoclonal antibodies
could identify the virus isolated from patients and their serotype. The
monoclonal antibodies produced might be useful not only as a research
tool but also as a diagnostic aid.
Study on T-lymphocyte subpopulations in patients with Korean hem-
orrhagic fever with renal syndrome by flow cytometer. C.H. Lee, W.
Kim, K.M. Hwang, 5K. Park, and S.K. Kang, Department of Internal
Medicine, Chonbuk University Medical School, Chonju, Korea. Ko-
rean hemorrhagic fever is an acute infectious disease caused by
Hantaan virus. Pathogenesis of Korean hemorrhagic fever is not clearly
delineated to date, Recently, the immunologic mechanisms of Korean
hemorrhagic fever have been studied by many investigators. To clarify
the role of immune mechanism in the. pathogenesis of Korean hemor-
rhagic fever, lymphocyte subsets were measured by flow cytometry in
the peripheral blood from 8 patients during the acute phase and 10
months after Korean hemorrhagic fever. During the acute phase of
Korean hemorrhagic fever, the percentage of CD4 was decreased and
CD8 and activated T cell were increased significantly compared to 10
months after Korean hemorrhagic fever. The present results suggested
that variation of lymphocyte subsets distribution may be occurred in
acute phase of Korean hemorrhagic fever, and it may be related to the
pathogenesis of Korean hemorrhagic fever.
Tissue distribution of Hantaan virus as an evidence of direct pathogenic
role of the virus. S. Kim, C. Ahn, J.S. Han, G.H. Kim, J.T. Cho, W.H.
Kim, V.1. Kim, and J.S. Lee, Department of Internal Medicine and
Pathology, Seoul National University College of Medicine, Seoul,
Korea. Many inflammatory mediators are known to play important
roles in the pathogenesis of KHF. On the other hand, we demonstrated
viral antigens in kidney biopsy specimens obtained from KHF patients,
and suggested a possibility of direct pathogenetic role of the virus itself.
To evaluate the tissue distribution of Hantaan viruses, we demonstrated
the viral antigens by immunohistochemistry, as well as isolating the
virus from various tissues obtained from autopsies. Autopsies were
done in 2 patients. The first case was a 19-year-old female from
Whasung, Kyoungki Do; the second case was a 21-year-old male from
Kimpo, Kyoungki Do. They died at the 12th day of illness in their
oliguric phases. The severity scores were 13 and 15, respectively.
Limited autopsy, excluding brain and spinal cord, was done in case 2.
The Hantaan virus antigens were stained by the Avidin-Biotin method
using 3 different monocional antibodies, 8E10, 6D4 and ECO2. The
specificity was ascertained by blocking specimens with semipurified
inactivated viruses and convalescent serum of a KHF patient. Hantaan
virus specific antigens were found in kidneys, liver, adrenal glands,
heart, pituitary gland and spinal cord in case 1; in kidneys, liver and
heart in case 2. On electron microscopic exam, the viral particles were
observed in hepatocytes and inclusion bodies in spinal cord. Inclusion
bodies were also stained by anti-Hantaan antibodies by immunoelec-
tron microscopy. In case 1, Hantaan virus was isolated by inoculating
the autopsy tissues to Vero E6 cells. The viruses were isolated from the
tissues from kidneys, lungs, pancreas and liver. In summary, we
demonstrated that Hantaan virus is distributed not only in the major
target organs—kidneys, pituitary gland and right atrium, but also in the
whole body. So we provided the possibility of the direct pathogenic role
of the virus itself as well as many inflammatory mediators.
Role of cytokines for protelnuria In the patients with hemorrhagic fever
with renal syndrome. Y.H. Lee, E.J. Lee, S.S. Kim, D.R. Cha, Y.J.
Kwon, W. Y. Cho, and H.K. Kim, Department of Internal Medicine,
College of Medicine, Korea University, Seoul, Korea. Recently, it was
proposed that T-lymphocytes infiltrated in renal interstitium might be
associated with abnormal renal function and proteinuria in HFRS.
Therefore, to speculate the role of cytokines including interleukin 2
(IL-2), interferon a (IFN a) and interferon y (IFN y) for proteinuria and
disrurbed renal function in HFRS, we performed IL-2 assay in serum
and urine, IFN a and IFN y assay by radioimmunometric method in 14
cases of serologically proven HFRS in the patients' urine during
oliguric and diuretic phases. The results were as follows: 24 hour
preteinuria in oliguric phase (731.6 106.9 mg/day) was significantly
higher than that in diuretic phase (90.9 89.8 mg/day). There was no
significant difference in serum concentration of IL-2 between the
oliguric and diuretic phase, but a significant difference compared with
that of control group, in oliguric and diuretic phase, respectively (P <
0.05). The excretion of urine IL-2 of HFRS patients in oliguric phase
(5.07 1.06 fmollmgCr) was significantly higher than that of diuretic
phase (0.35 0.05 fmol/mgCr) and control group (0.78 0.27 fmoll
mgCr) (P < 0.05). The excretion of urine IFNa (5.27 4.27 U/mgCr),
IFN y (2.25 1.44 U/mgCr) in oliguric phase was higher than that in
diuretic phase (IFN a: 0.27 1.12 U/mgCr, IFN y 0.12 0.12
U/mgCr) (P <0.05). There was positive correlation between serum IL-2
and 24 hour proteinuria (r = 0.67, P = 0.018), and urine IL-2 showed
reverse correlation with Ccr (r =
—0.69, P = 0.013) and positive
correlation with the 24 hour proteinuria (r = 0.80, P = 0.003). Urine
IFN a and IFN y showed reverse correlation with Cr (r =
—0.61, P =
0.03 and r =
—0.67, P = 0.017, respectively) and positive correlation
with the amount of 24 hour proteinuria (r = 0.80, P = 0.003 and r
0.94, P = 0.001, respectively). From the above findings it may be
concluded that cytokine including IL-2, IFN a and IFN y may have a
significant role for proteinuria and renal dysfunction in the HFRS.
Transendothelial migration of mononuclear cells in hemorrhagic fever
with renal syndrome (HFRS). J.S. Lee, K.C. Kwak, D.J. Oh, E.T.
Kang, S.!. Chung, C.S. Choi, and S.H. Vu, Department of Internal
Medicine and Microbiology, College of Medicine, Chung-Ang Univer-
sity, Seoul, Korea. In HFRS the basic pathogenesis is the increase in
vascular permeability and infiltration of mononuclear cells. We had
previously demonstrated the infection and proliferation of Hantaan
virus in human umbilical vein endothelial cells (HUVEC). We have
investigated the effect of viral infection on vascular permeability to
mononuclear cells. HUVECs are isolated and passaged two times.
HUVECs which were cultured on Transwell plate (Costar, USA) were
infected with Hantaan virus (100 times of 1D50). Mononuclear cells
were isolated by Ficoll-Hypaque method and labeled with 5tCr.
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Transendothelial cell migration and adhesion on HUVEC were mea-
sured and confirmed by transmission electron microscopy. Mononu-
clear cell adhesion to infected HUVEC increased markedly to 19.2%,
16.2%, 25.5%, 16.7%, and 17.5% after inoculation of 6 hours, 12 hours,
18 hours, 24 hours and 72 hours, respectively (control, 12%). Transen-
dothelial migration increased to 8.15%, 8.45%, 10.96%, 9.87% and
8.21% after inoculation of 6 hours, 12 hours, 18 hours, 24 hours and 72
hours, respectively (control, 3.86%). These results suggest the Hantaan
virus affects vascular endothelial cells directly to increase permeability
of blood cells and plasma components.
An analysis of 1,000 consecutive renal biopsies. S.H. Lee, S.B. Park,
and H.C. Kim, Department of Internal Medicine, Keimyung University
School of Medicine, Taegu, Korea. We analyzed 1,000 consecutive
adult renal biopsies (593 males and 407 females) performed at the
Keimyung University Hospital between December 1978 and February
1993. Their mean age was 33.3 13.4 years with extremes of 15 and 75
years. The clinical diagnoses at the time of renal biopsy were: nephrotic
syndrome (508 cases), graft kidney dysfunction (187 cases), urinary
abnormalities (134 cases), lupus erythematosus (67 cases), unexplained
renal failure (53 cases), acute nephritic syndrome (15 cases), H-S-P (9
cases), and multiple myeloma (6 cases). Of the 813 cases excluding graft
kidney biopsy diagnosis was made by LM, IF, and EM in 548 (67.1%)
cases, by LM and EM in 88 (10.8%) cases, by LM and IF in 48 (5.9%)
cases, by LM only in 129 (15.9%) cases. The histological diagnoses of
the biopsies were MCNS (27.7%), IgA nephropathy (16.7%), FSGS
(9.1%), lupus nephritis (8.1%), CGN (4.6%), MPGN (4.4%), MsPGN
(2.8%), interstitial nephritis (1.5%), crescentic glomerulonephritis
(0.9%), and H-S-P (0.9%), in decreasing order of frequency. Adequate
tissue for histologic diagnosis was obtained in 100% by CT control, in
98.8% by ultrasound, in 92.8% by fluoroscopic control, and in 48% by
IVP control. The following complications were obtained: microscopic
hematuna (34.9%), gross hematuria (7.0%), loin pain or tenderness
(6.4%), and renal failure (0.6%). Bleeding complications requiring
transfusion and/or therapeutic intervention were seen in six patients
(0.6%). No deaths have been observed in our series. The diagnostic
adequacy rate and mean numbers of glomeruli were correlated with the
number of the cores of renal tissue yield at biopsies (P < 0.001);
however the complication rate was not significantly different among the
groups.
Urine urokinase activity in the anti-glomerular basement membrane
(GBM) antibody induced crescentic nephritis in the rabbit. R. W. Chun,
K.H. Kim, Y.C. Lee, D.W. Chae, J.W. Noh, and S.Y. Hong, Division
of Nephrology, Department of Internal Medicine, Hallym University
Hospitals, Seoul, and Soonchunhyang University Hospital, Chunan,
Korea. It is well-known that fibrin deposition and fibrinolytic activity
are increased in glomerulonephritis. But each of two major fibrinolytic
activities in the kidney, t-PA and urokinase, still remain to be eluci-
dated. We induced the crescentic nephritis, which is characterized by
fibrin deposition in the Bowman's space, and proliferation of parietal
epithelial cells, in New Zealand White rabbits by injection of guinea pig
anti-rabbit anti-GBM antibody. We checked the urokinase activity in
urine which is regarded as the most important fibrinolytic activity in the
glomeruli in which crescent is being formed, using the ELISA method
and the chromogenic peptide substrate, S-2444. Acquired urokinase
activity of urine was standardized by dividing urokinase activity with
urine creatinine concentration of the same urine sample. We observed
and analyzed the standardized urokinase activity of urine samples
before and after inducing crescentic nephritis (Day 0, 1, 2, 4, 7, 14) in
relation to the degree of crescent formation. Results were as follows: (1)
ELISA method was used for detecting antigenicity of human urokinase,
but did not work at all in detecting that of rabbit urokinase. (2)
Regardless of severity of crescent formation, urine urokinase activity of
Day 7 increased significantly compared with that of Day 0 (P < 0.05).
(3) Urokinase activity of the urine of cases with crescent formation over
30% was significantly lower than that of cases with crescent formation
less than 10% (P < 0.001). (4) Urokinase activity of the urine of cases
with crescent formation over 30% increased significantly only at Day 7
compared with that of Day 0, but urokinase activity of the urine of cases
of crescent formation less than 10% increased significantly at Days 2,4,
and 7 compared with that of Day 0 (P <0.05). From the above findings,
we conclude that antigenicity of human urokinase was different from
that of rabbit, and that low urokinase activity and/or early increase of
urokinase activity of urine might suggest one of the possible mecha-
nisms for suppressing development of crescent formation.
The relationship between proteinuria and renal progression in diabetic
nephropathy. E.J. Choi, J. 1'. Woo, P.K. Kim, Y.S. Chang, Y.S. Yoon,
S.K. Kang, andB.K. Bang, Department of Internal Medicine, Catholic
University Medical College, Seoul, Korea. To evaluate whether the
proteinuna is one of the factors in the progression of diabetic nephrop-
athy, we examined the [Cr] slope as the index of the renal progres-
sion, 24 hour urine protein, and the various chemical values of serum in
the 29 patients (M:F = 16:13) of clinical diabetic nephropathy. Accord-
ing to the maximum serum creatinine (MSC) during observation period,
we classified these patients as group A (MSC < 2 mg/dl, N = 12), group
B (MSC > 2 mg/dl, N = 11) and group C which has break point in its
own slope. Groups B and C were subgrouped as group Bl (slope >
—0.01, N = 6), group B2 (slope < —0.01, N = 5) and group C as group
Cl (pre-break point, N = 7) and group C2 (post-break point, N = 7).
There were no differences of the observation periods (mean 38—65
months), mean HbA1C, mean BP, and mean cholesterol between
groups.
Group
MSC
mg/dl
Albumin
gidI
U0
glday
Slope x l0
mg/dl/month
A 1.2 0.1 3.3 0.2 2.3 0.4 —1.9 4.8
Bi 4.4 0.7 3.6 0.2 2.2 1.1 —0.7 1.6
B2 6.2 1.6 2.8 0.5 4.2 0.7 —34.0 38b
Cl 1.1 0.1 3.4 0.3 1.6 0.5 —9.4 4.8
C2 2.9 0.4a 2.8 0.2a 5.6 l.la —22.8 8.9a
Values are Mean SE, a p < 0.05 Cl vs. C2, b p < 0.05 Bl vs. B2.
In spite of differences of [Cr]' slope between BI and B2 there were no
differences of the serum albumin and the 24 hour U protein. But the
slope of C2 was different from that of Cl, and the serum albumin and
the 24 hour U0 of C2 were different from Cl. These results suggest
that proteinuria is in part one of the progression factors in diabetic
nephropathy.
Lovastatin prevents glomeruloscierosis in streptozotocin-induced dia-
betic uninephrectomized rats D.C. Han, S.K. Lee, S.D. Hwang, and
H.B. Lee, Hyonam Kidney Laboratory, Soon Chun Hyang University,
Seoul, Korea. To evaluate the effect of the lipid-lowenng agent,
lovastatin (L), on the progression of glomerulosclerosis in diabetic
glomerulopathy, a total of 23 SD rats was studied for 20 weeks following
induction of diabetes mellitus (DM) with i.v. streptozotocin. Fifteen
diabetic animals were uninephrectomized 4 weeks after the induction of
DM and 8 of these 15 animals received subcutaneous L (DNL). Seven
animals did not receive L and served as uninephrectomized diabetic
controls (DN). The remaining 8 animals did not undergo unincphrec-
tomy nor received L and served as diabetic controls (D). In group D,
BUN, total cholesterol (TC) and triglyceride (TG) rose progressively,
and the levels at 20 weeks were significantly higher than baseline
values. Daily urinary protein excretion (DPU) also increased progres-
sively until 20 weeks, but the difference did not reach statistical
significance. There was very little mesangial expansion (score of 0.62)
or glomerulosclerosis (0.38%) in these animals until 20 weeks. In DN,
BUN, TC, TG and DPU increased progressively and significantly over
the baseline values and, at 20 weeks, were significantly higher than in D
rats. Kidney weight at this time was significantly heavier than in group
D. There were significant increases in mesangial expansion (score of
2.18) and glomerulosclerosis (3.29%). In DNL, all the changes seen in
DN with the exception of kidney weight and mesangial expansion were
suppressed and the changes were not different from group D rats. In
conclusion, little mesangial expansion or glomeruloscierosis was ob-
served in streptozotocin-induced diabetic rats until 20 weeks after
induction of DM. Both increased significantly by uninephrectomy 4
weeks after induction of DM. Glomerulosclerosis was almost com-
pletely prevented by L. Suppression of renal hypertrophy and mesan-
gial expansion was, however, incomplete.
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Changes of soluble interleukin-2 receptor and T.lymphocytic subpop-
ulations in children with minimal change nephrotic syndrome. C. W. Ko
and J.H. Koo, Department of Pediatrics, Kyungpook National Univer-
sity School of Medicine, Taegu, Korea. A prospective study was
conducted to evaluate the role of T-lymphocytes in the pathogenesis of
minimal change nephrotic syndrome (MCNS). Study population con-
sisted of 19 children (aged 3 to 15 years) with biopsy-proven MCNS.
Serum soluble interleukin-2 receptor (s-IL2R) and peripheral blood
T-lymphocytic subpopulations (T4, T8 cells) were determined during
relapse and 1 month after remission period, and the following results
were obtained: s-IL2R (pg/ml) values were 1879 928 during relapse
and 1554 445 one month after remission; there was no significant
change between two periods, and these values were not significant
compared to control of 1942 815. Populations of T4 cell (%) were32.3
6.9 during relapse and 33.7 7.9 one month after remission; these
values were also not significant compared to control of 27.7 5.4.
However, populations of T8 cells (%) during relapse and 1 month after
remission were significantly increased, 33.7 7.7 and 41.0 8.0
respectively, compared to control of 27.7 5.4. In summary, it can be
said that T4-lymphocytes do not play an important role in the patho-
genesis of MCNS.
Interleukin-4 (IL-4) activities and mRNA expression In childhood
minimal change nephrotic syndrome. Byoung-Soo Cho, Choong-Eun
Lee, and Kwang-Ho Pyun, Department of Pediatrics, College of
Medicine, Kyung Hee University, and Immunology Research Labora-
tory, Genetic Engineering Research Institute, KIST, Korea. We have
previously reported that peripheral B cells of patients with childhood
MCNS express higher levels of Fc rR II (low affinity IgE receptor),
which is well correlated with increased IL-4 activities in their sera. Yet
B cells' responsiveness to exogenous LL-4 is similar for MCNS and
normal controls, By analyzing IL-4 production from T cells at the
molecular level using Northern blot for IL-4 mRNA, we now present
further evidence that MCNS involves a T cell disorder. Significantly
higher levels of IL-4 mRNA expression by mitogen activated T cells
were noted for MCNS than normal or disease controls. In addition,
there was a strong correlation between the T cells' capacity to express
IL-4 mRNA and the IL-4 activities measured in the culture supernatant
of T cells, which in turn, correlated with elevated serum IgE, soluble
FcsR II, and membrane FcsR II in MCNS. However, mRNA expres-
sion levels of interferon-y, a cytokine which antagonizes IL-4 activities
to inhibit IgE and FcsR II production, were similar in normal controls
and MCNS. These results indicate that a T cell abnormality in the
over-expression of IL-4 may play a role in the pathogenesis of MCNS.
Long-term follow-up of nephrotic children with focal segmental gb-
merulosclerosis. J. Huh, I.S. Ha, H.I. Cheong, Y. Choi, and K. W. Ko,
Department of Pediatrics, Seoul National University College of Med-
icine, Seoul, Korea. We analyzed the long-term outcome of 39 children
with idiopathic nephrotic syndrome who were diagnosed as focal
segmental glomerulosclerosis (FSGS) and followed-up over 5 years.
Mean follow-up duration was 8 years and 8 months. Median age at onset
was 5 years and 7 months. They consisted of 31 boys and 8 girls.
According to the responsiveness to initial steroid therapy, complete
remission (CR) was observed in 23 patients (59%), partial remission
(PR) in 13 (33%), and no remission (NR) in 3 (8%). There were no
significant differences in clinicopathological findings among three
groups such as onset age, sex ratio, hypertension, hematuria, glucos-
uria, selectivity index, creatinine clearance, segmental sclerosis, tubu-
lointerstitial change, etc. Overall maintenance rate of normal renal
function in 39 patients was 95% after 5 years and 73% after 10 years
without significant differences among the three groups. Similarly, in the
CR group the proportion of renal insufficiency and renal death was 4.3%
at 5 years and 28.6% at 10 years. Based on the pathological findings, 16
patients with more than 20% of segmental sclerosis tended to have
higher proportion of the deterioration of renal function than those with
less than 20% of segmental sclerosis. Also, according to the degree of
tubulointerstitial changes, a higher tendency of renal deterioration was
noted in patients with more severe tubulointerstitial changes. The data
suggest that the long-term outcome correlate with the pathological
findings, such as segmental sclerosis and tubulointerstitial changes, but
not with the responsiveness to initial steroid therapy.
Cyclosporine in the adult nephrotic syndrome. S.S. Cho, S.H. Lee,
SB. Park, and H.C. Kim, Department of Internal Medicine, Keimyung
University Hospital, Taegu, Korea. The efficacy of cyclosporin A was
examined in 15 adult patients with steroid dependent (9 patients),
frequently relapsing (2 patients), steroid resistant nephrotic syndrome
(2 patients), and other glomerulonephritis (2 patients). Cyclosporine
was started at an initial dose of 5 mg/kg/day in two divided doses.
Cyclosporine induced complete remission in 11(73.3%) patients, partial
remission in 3 (20%) patients, and no response in 1 (6.7%) patient.
There was no correlation between the previous response to steroid
therapy and efficacy of cycbosporine. All 14 (100%) patients went into
remission within 4 weeks of starting treatment with cyclosporine.
Serum albumin rose significantly (P < 0.01) from 3.42 g/dl to 4.36 g/dl
at 3 months after treatment. There were no significant changes in blood
chemistries including BUN, serum creatinine, potassium, and uric acid
during cyclosporine treatment. Tolerance to the treatment was excel-
lent. Minor side effects, such as tremor, hypertrichosis, and hyperten-
sion, were reported in a small number of patients. Only one patient
required interruption of treatment. Blood pressure and the serum
creatinine level were stable throughout the study in most of the
patients. Relapse occurred in eight (88.8%) out of 9 patients within a
mean time of 5.6 weeks after withdrawal of cyclosporine. In conclusion,
cyclosporine may be a good alternative to steroids in the treatment of
minimal change nephrotic syndrome, particularly in steroid dependent
and frequent relapsers who are at high risk of developing steroid
toxicity. Prolonged administration of cyclosporine is needed to achieve
continued remission because of the high incidence of relapses on
withdrawal of cyclosporine.
Evaluation of nephrotoxicity during cyclosporin A treatment in pedi-
atric nephrotlc syndrome patients. Y.J. Lee, H.O. Rob, M.S. Park, P.K.
Kim, H.J. Jeong, and I.J. Choi, Departments of Pediatrics and
Pathology, Yonsei University College of Medicine, Seoul, Korea. Until
now, corticosteroid hormone, cyclophosphamide, and chlorambucil
were the immunosuppressants for the treatment of nephrotic syndrome
in the pediatrics. This study is about the therapeutic effect of cyclospo-
rin A in primary nephrotic syndrome, and secondary nephrotic syn-
drome of Henoch-Schönlein pupura nephritis and Ig A nephropathy,
and also the side effects including nephrotoxicity which is seen by
prerenal biopsy. Patients were treated with cyclosporin A for 8 months.
Before and after the medication renal biopsy was performed and OPD
follow-up was also possible in the 34 cases studied, Serum protein,
albumin, BUN, creatinine, serum uric acid, 24 hour urine protein, and
the recurrence before and after the treatment of cyclosporin A, were
analyzed using PC-SPSS. The side effects of cyclosporin A were also
studied. The results are as follows: (1) There was a significant difference
in serum protein, albumin and 24 hour urine protein by the treatment of
cyclosporin A in minimal change nephrotic syndrome patients (P <
0.05). (2) There was a significant decrease in the recurrence of minimal
change nephrotic syndrome during a 6 month period after the treatment
with cyclosporin A (P < 0.01). (3) There was a significant increase in
serum albumin after the treatment with cyclosporin A in membranous
glômerubonephropathy, Henoch-Schonlein purpura nephritis patients(P < 0.05). (4) After the treatment with cyclosporin A, hypertrichosis,
hypertension, chicken pox infection, elevated liver enzyme and tremor
were observed. (5) Three out of 34 cases were suspected of cyclosporin
A toxicity, who had renal interstitial fibrosis or renal tubular atrophy
upon renal biopsy, but the severity was not significant.
Llpoprotein(a) levels in patients with nephrotic syndrome. Sae Yong
Hong and Dong Ho Yang, Department of Internal Medicine, Soon-
chunhyang University Chunan Hospital, Chunan City, Choongnam,
Korea. Recently there has been a renewed interest in the possibility that
Lp(a) may be important in the pathogenesis of thrombosis related
disease. It is already known that lipoprotein levels in patients with
nephrotic syndrome are usually high, so it would be very interesting to
see if Lp(a) levels are also elevated in these patients. If Lp(a) levels
increase concomitantly to LDL and/or VLDL in nephrotic syndrome, it
should be considered a thrombogenic factor. To probe this possibility,
we measured the Lp(a) levels in the following patients: nephrotic
syndrome (N = 43), chronic glomerulonephritis patients with protein-
uria, less than 3 g per day (N = 28), and healthy control (N = 50). Lp(a)
was 714.9 458.3 mg/liter in the nephrotic syndrome group, 293.7 ±
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199.4 mg/liter in the chronic glomerulonephritis group, and 165 33
mg/liter in the healthy control group, showing significantly higher levels
in the nephrotic syndrome group compared to both the chronic glomer-
ulonephritis group and healthy control group (P < 0.001). Lp(a)
concentrations showed a direct correlation with serum cholesterol level
(R-squared = 0.609, P = .0001), triglyceride level (R-squared = 0.198,
P .0001), urine protein level (R-squared = 0.456, P = .0001) but an
inverse correlation with serum albumin levels (R-squared = 0.32, P =
.0001). Lp(a) concentration according to the lipoprotein pattern was
961.4 416.6 mg/liter for type lib (N = 22) and 484.1 320.4 mg/liter
for type IV (N = 26), showing significantly higher levels for type lib
compared to type IV (P < 0.001). Our results suggest that Lp(a) should
be considered a thrombogenic factor in nephrotic syndrome.
Clinical and pathologic characteristics of adult Henoch-Schonlein ne-
phritis(HSN). K.)'. Na, Y.C, Jung, C. Ahn, J.S. Han, S. Kim, andJ.S.
Lee, Department of Internal Medicine, Seoul National University
College of Medicine, Seoul, Korea. Henoch-Schönlein purpura, a
disease that frequently involves the kidney is a disease of children less
than 4 years of age. There have been many reports on the clinical
outcome according to initial presenting symptoms, pathologic findings,
and treatment of HSN in children, but those of HSN in adults were not
well-known. To evaluate the clinical and pathologic features in adult
patients, we studied 33 HSN patients who were diagnosed as HSN by
having purpura and diffuse mesangial IgA deposits on renal biopsy.
These patients were admitted to SNUH from 1979 and 1991. (1) The
median age at diagnosis was 26 years, and the male to female ratio was
17:16. (2) Abdominal pain was observed in 28 (84%), gastrointestinal
bleeding in 7 (21%), and arthralgia in 19 (58%). Of these, 6 patients had
all of those three items. (3) The clinical syndrome at diagnosis was
asymptomatic urinary abnormalities in 17 (52%), chronic glomerulone-
phritis in 6 (18%), nephrotic syndrome in 6 (18) and acute glomerulo-
nephntis in 4 (12%) patients. (4) Serum IgA levels were elevated in 16
(48%). Serum C3 levels were normal in all cases, and serum C4 levels
were reduced in 1(3%) and serum CH5O in 5 (15%). (5) The pathologic
diagnosis according to ISKDC classification was class III in 26 (79%),
class II in 5(15%) and class IV in 2(6%). (6) According to the Meadow's
classification (1972), out of 21 patients who were followed-up more than
6 months, 4 were classified as stage A (normal), 10 as stage B (minor
urinary abnormalities), 5 as stage C (proteinuria> 1 g/day hyperten-
sion), and 4 as stage D (renal insufficiency). No significant correlation
between clinical courses and clinical syndrome at diagnosis or his-
topathologic findings was found.
Wegener's granulomatosis with rapidly progressive glomerulonephritis
and low dose of sulfamethoxazole-trimethoprim. H.J. Kim, C.I. Sohn,
C.H. Park, C.M. Kang, H,C. Park, and Y.H. Koh, Departments of
Internal Medicine and Pathology, Hanyang University Hospital, Seoul,
Korea. The efficacy of conventional cytotoxic treatment with cyclo-
phosphamide for Wegener's granulomatosis (WG) has been well-
known, but its use was frequently limited by toxicity or drug resistance
and, as a recent advance in treatment of WG, sulfamethoxazole-
trimethoprim was tried successfully in scattered reports. In this report
we present two men (65 and 58 years old) diagnosed simultaneously as
WG with rapidly progressive glomerulonephritis proven by percutane-
ous renal and open lung biopsy in whom cyclophosphamide as the initial
conventional therapy was discontinued due to severe toxicity and
infections. Then, the lower doses of sulfamethoxazole-trimethoprim
than those of previous trials reported by DeRemee et al and Israel HL,
400 mg/day of sulfamethoxazole and 80 mg/day of trimethoprim, was
replaced for cyclophosphamide in these two patients. During the past 6
months with this regimen, they improved clinically and remained in
remission. As evidence of the sustained remission, the uremia requiring
hemodialysis initially was resolved up to serum creatinine ranging from
1.7 to 2.9 mgldl without hemodialysis and initial high positive titer
(>1:320) of antineutrophil cytoplasm antibody (ANCA), recently
known as a sensitive marker of disease activity of WG remained
negative. Though only two cases of WG in this report were tried on this
low dose of sulfamethoxazole-trimethoprim and were followed for a
short period (6 months) so far, its remarkable clinical efficacy with more
safety than other regimen for WG could be promising for its further
trials or for the replacement of cyclophosphamide in the future.
Renal amyloidosis. W.S. Huh, Y.S. Kim, C. Ahn, J.S. Han, S. Kim,
and J.S. Lee, Department of Internal Medicine, Seoul National Uni-
versity College of Medicine, Seoul, Korea. The proportion of renal
amyloidosis in nephrotic syndrome is known to be 3% in Western
countries. But since 1982, only 8 cases of renal amyloidosis have been
reported, and there has been no clinical case study done on this disease
in Korea. To find out clinical features, we retrospectively analyzed 16
out of 19 patients who were diagnosed as renal amyloidosis on kidney
biopsy, from 1979 to 1992, in Seoul National University Hospital. (I)
One percent of total kidney biopsy patients with glomerulonephritis had
renal amyloidosis (19/1893). The male and female ratio was 9:7. The age
ranged from 46 to 73 years (mean 53 years). (2) Underlying diseases
were multiple myeloma (4 cases) and Castleman's disease (1 case). The
others (11 cases) were primary amyloidosis. (3) Foamy urine was
observed in all 16 patients. Leg edema was found in 10 patients,
hepatosplenomegaly in 7, dyspnea on exertion in 2, orthopnea in 1,
peripheral neuropathy in 1, macroglossia in 1, soft tissue hypertrophy in
1, and hematoma in 1 patient. Extrarenal involvements occurred in
heart (2 patients), liver (7 patients), soft tissue (1 patient), and nervous
system (1 patient). (4) Proteinuria was observed in all patients. Eleven
patients (69%) had nephrotic range proteinuria. Microscopic hematuria
was observed in 3 patients (19%), azotemia in 6 (38%), anemia in 5
(3 1%), and hypercholesterolemia in 11 patients (69%). (5) On serum
immunoelectrophoresis, M peak was observed in 10 patients; IgG in 5,
IgA in 3, kappa in 1, lambda in 9. (6) Amyloid fibrils were deposited on
glomerulus (16 patients), renal tubule (15 patients), and interstitium (15
patients) on the histologic exam.
Correlation of the phenotype and the mode of inheritance in Alport
syndrome using an Alport-specific antibody probe. H.W. Park, H.i.
Cheong, i.S. Ha, and Y. Choi, Department of Pediatrics, Seoul
National University College of Medicine, Seoul, Korea. Alport syn-
drome (AS) is a phenotypically and genetically heterogenous disorder,
and the clinical heterogeneity may reflect the involvement of different
genes. Recently, several mutations have been identified in type IV aS
collagen chain (COL4A5) gene in part of AS kindreds with X-linked
dominant (XD) inheritance. However, nothing is known about the
involved gene(s) or protein(s) in AS with autosomal inheritance. We
analyzed the clinical findings of 19 AS families. Fifteen families
revealed XD inheritance and 2 autosomal inheritance. Another 2
patients were sporadic cases. Early renal failure (juvenile type), senso-
rineural hearing loss and ocular abnormalities were noted in 4, 12, and
3 families, respectively, and the incidences were not different between
XD families and others. We also studied the antigenic defect in
epidermal basement membrane (EBM) with Alport-specific antibody
probe (Mab Al, provided by Dr. A.F. Michael, University of Minne-
sota, USA), which reacts with the Alport antigen (possibly NCI of
aS(IV) collagen). The antibody failed to react with the EBM in 12 out of
15 XD families and none of the other 4. The clinical features were not
different between Alport antigen defective and intact families. These
findings suggest that the clinical findings were similar regardless of the
mode of inheritance or presence of the antigen in EBM. However, the
defective gene(s) might be other than COL4A5 in non-XD patients.
Incidental diagnosis of Fabry's disease in a man with intermittent trace
proteinuria. H.J. Kim, I.S. Park, C.H. Park, G.M. Kang, H.C. Park,
and Y.H. Koh, Departments of internal Medicine and Pathology,
Hanyang University Hospital, Seoul, Korea. Fabry's disease is a rare,
inherited X-linked metabolic storage disease with ceramide hexoside
due to a-galactosidase A deficiency. The patients with Fabry's disease
usually present with either one or some of several clinical manifesta-
tions of angiokeratomata, corneal dystrophy, neurological abnormali-
ties, cardiovascular diseases and renal involvement with pathologically
significant heavy proteinuria. However, we report a 34-year-old man
who might have been unrecognized as a Fabry's disease due to the
paucity of clinical signs and symptoms, except intermittent trace
proteinuna, when he was examined due to back pain following heavy
exercise. This patient with no history of renal disease in any other
family member was noticed to have intermittently trace or I (+)
proteinuria on routine dipstick urinalysis but less than 300mg of protein
in 24-hour urine. He underwent a percutaneous renal biopsy with his
full understanding of its benefits and risks. It revealed typical findings of
Fabry's disease which was not suspected at all before the renal biopsy
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as a differential diagnosis. Subsequent to renal biopsy, skin biopsy on
initially unrecognized few scattered dark-pinkish scrotal papules and
biochemical enzymatic assay of a-galactosidase in leukocytes, plasma
and urine were performed to confirm the diagnosis of a Fabry's disease.
Therefore, we learned from this case that the possibility of Fabry's
disease could be considered even in the presence of asymptomatic
intermittent trace proteinuria.
Treatment of hepatitis B virus-associated glomerulonephrltis (HBV-
ON) with recombinant human alpha interferon (a-IFN). D.R. Chung,
W.S. Yang, S.B. Kim, E. Yu, Y.H. Chung, Y.S. Lee, 1.5. Park, and
C.D. Hong, Department of Internal Medicine, Department of Pathol-
ogy, University of Ulsan, Seoul, Korea. The pathogenesis and effective
treatment of HBV-GN remain undefined, HBeAg is claimed to play an
important role in the pathogenesis of membranous type of HBV-GN
(MGN) and membranoproliferative type of HBV-GN (MPGN), and
there are reported cases that n-IFN induced remission of the nephrotic
syndrome with concurrent disappearance of HBeAg. To evaluate the
therapeutic effect of a-IFN in patients with HBV-GN, six male adult
patients who were (1) positive in serum HBsAg, HBeAg and HBV-
DNA, (2) showing chronic active hepatitis on liver biopsy, (3) having
persistent proteinuria of greater than 1 gram per day, and (4) showing
glomerulonephritis on kidney biopsy, received a-IFN at a dose of 3
million units, subcutaneous, three times a week. Kidney biopsy showed
MPGN in 3, mesangial proliferative ON (MesPGN) in 2, and MGN in 1.
Five of the six patients received a 6 month course therapy and the other
one with MGN quit therapy 2 months after initial doses because of
myalgia. The changes of hepatitis B viral markers and proteinuna were
monitored. In 4 of the 5 patients who received a 6 month therapy, serum
HBeAg and HBV-DNA disappeared and anti-HBe appeared during the
therapy (in 3.8 2.2 months, mean SD). In 2 of these 4 patients,
HBeAg and HBV-DNA reappeared, I during s-IFN therapy and the
another in 5 months after the last dose of a-IFN. Hepatitis B viral
markers of 1 patient who received a 2 month therapy did not change. In
all 3 patients with MPGN, serum HBeAg was converted to negative,
but the amount of proteinuria didn't change. The follow-up renal biopsy
done in 2 of these 3 patients also showed no change. Both patients with
MesPON showed remission of proteinuria; however, only 1 patient had
seroconversion of HBeAg. In a patient with MGN who received a 2
month therapy, proteinuria persisted. In conclusion, there appears to be
no association between the seroconversion of HBeAg and the remission
of proteinuria in MPGN and MesPON. The effectiveness of the a-IFN
therapy for HBV-ON may differ according to the pathology.
Effects of angiotensin converting enzyme inhibitor (ACEi) in patients
with hepatitis B virus (HBV) and glomerulonephritls (GN). C.G. Ihm,
H.J. Cheong, K.S. Ko, J.H. Ahn, T. W. Lee, and M.J. Kim, Division of
Nephrology, Kyung-Hee University Medical Center, Seoul, Korea.
Immunosuppressive therapy (1ST) may provide harmful influences in
HBV associated GN. ACEi is suggested to have beneficial effects on
proteinuria and the progression of glomerular diseases. Therefore, the
long-term effects of ACEi (captopril or enalapril) were evaluated in 11
patients with HBV and proteinuria >2.0 g/24 hr. Especially, 6 patients
with IgA ON and HBV among them were compared with 17 patients
with idopathic IgA GN with proteinuna who received 1ST. Mean
follow-up was 18.6(9—37) months. No significant changes were detected
in mean arterial pressure (113 32 vs. 97 11 mm Hg) and serum
creatinine (1.2 0.7 vs. 1.2 0.6 mg/dl) between before and after
ACEi. Serum creatinine remained normal in most patients, except 2; it
fell in 1(3.0 — 1.7) and increased in 1(1.7—* 2.6). Proteinuria decreased
from6.9 5.8(range2.0—22.0)to2.0 l.7(0.04—5.5)g/24hr(P< 0.01),
and serum albumin increased from 3.2 0.8 to 4.1 0.4g/dl (P < 0.05).
Proteinuria decreased in all patients, by above 50% within 3 months in
7, and to <1.5 g/24 hr in 8 and to <0.5 g124 hr in 3 during follow-up.
Serum lipid levels tended to decrease, but there was no significant
change. Liver function test was abnormal in only one patient with
chronic active hepatitis, but serum OPT fell from 657 to 126 units after
ACEi. In patients with IgA GN and HBV who received ACEi, the
results were similar to those with idiopathic IgA ON who received 1ST.
In conclusion, ACEi may have beneficial effects on proteinuria and
progression in patients with HBV and ON, especially IgA ON, without
adverse effect on liver. Long-term follow-up is necessary to clarify this.
Antineutrophil cytoplasmic autoantibody-associated glomerulonephri-
tis. Yl. Choi, Y.S. Yoon, BK. Kim, S.M. Kim, D.C. Jin, Y.S. Kim,
I.S. Park, EJ. Choi, Y.S. Chang, B.K. Bang, and S.!. Shim, Depart-
ments of Clinical Pathology, and Internal Medicine, Catholic Univer-
sity Medical College, Seoul, Korea. Antineutrophil cytoplasmic anti-
bodies (ANCA) are recently well-known as a diagnostic serologic
marker in a number of necrotizing vasculitis including Wegener's
granulomatosis (WO), and pauci-immune necrotizing glomerulonephn-
tis (ON). Indirect immunofluorescence microscopy demonstrates three
distinct staining patterns: the cytoplasmic ANCA (C-ANCA), perinu-
clear ANCA (P-ANCA), and granulocyte specific-antinuclear antibody
(GS-ANA). To investigate the incidence and clinicopathologic signifi-
cance of ANCA in GN with or without systemic vasculitis, we analyzed
121 sera from patients with renal disease. ANCA were detected in
26/121 patients (22%) with clinical diagnosis and 15/72 patients (21%)
with pathologic diagnosis. Of these 15 patients, ANCA results in each
pathologic diagnosis are as follows:
Immune complex Renallesion Systemic
Pauciimmune Lupus Non-lupus only lesion
C-ANCA 6 0 3 5 4
P-ANCA 1 4 0 0 5
GS-ANA 0 1 0 0 1
Total 7 5 3 5 10
Pathologically, focal or diffuse crescent formation was variably found in
ANCA associated ON (mean, 24%), especially predominant in pauci-
immune ON (37%). We conclude that ANCA are detected in 22% of
clinically and 21% of pathologically diagnosed renal diseases. C-ANCA
are frequently found in pauci-immune and non-lupus IC ON with or
without extrarenal lesions. P-ANCA are predominantly found in lupus
nephritis.
Clinical study of lupus nephritis. Won Kim, Chang H. Lee, Sung K.
Park, and Sun g-Kyew Kang, Department of Internal Medicine, Chon-
buk University Medical School, Chonju, Korea. Systemic lupus erythe-
matosus (SLE) is a disease of unknown origin, but the pathogenic
mechanisms are becoming clearer. Lupus nephritis has long been
considered one of the most ominous components of SLE. Forty
patients meeting the criteria of the American Rheumatism Association
for the diagnosis of SLE were retrospectively analyzed, from 1979 to
December 1992 in our hospital. Thirty-two patients who had lupus
nephritis with complete follow-up have been included in the long-term
prognosis study. The SLE group consisted of 37 females and 3 males
who had a mean age of3l years (range 18 to 67 years). Thirty-two lupus
nephritis patients had proteinuria and mean GFR (Ccr) of 78.2 mI/mm.
Renal failure developed in 4.8%. Twenty renal biopsy specimens from
patients with lupus nephritis had diffuse proliferative nephritis (70%).
Eleven patients were treated with a combination of prednisolone with
cyclophosphamide, and the rate of complete remission and non-re-
sponse was 54.5% and 9.1%, respectively. Twenty-one treated with
prednisolone alone had 19% complete remission and 28.6% non-
response. Lupus nephritis therapy seems to favor treatment with a
combination of prednisolone and cyclophosphamide.
The clinical and pathologic features of lupus nephritis in males. W.K.
Chung, C.S. Lim, C. Ahn, Y.G. Kim, J.S. Han, S. Kim, and 1.5. Lee,
Department of Internal Medicine, Seoul National University College of
Medicine, Seoul, Korea. The marked gender influence on the occur-
rence of systemic lupus erythematosus (SLE) indicates that genetic and
hormonal factors would be important in the etiology of this illness.
However, the clinical and pathologic features in male SLE patients are
not well-known. We studied 17 male lupus nephritis patients who had
kidney biopsies between 1979 and 1993 at Seoul National University
Hospital. The male to female ratio was Ito 6 during this period. Age at
kidney biopsy ranged from 16 to 59 years (median 28 years). The clinical
manifestations at kidney biopsy showed nephrotic and nephritic syn-
drome in 8(47%), acute nephritis inS (29%), and nephrotic syndrome in
2 (12%) patients. Hypertension and edema were observed in 12 (70%)
and 11(64%) patients, respectively. Nephrotic range proteinuria (>50
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mg/kg/day) and azotemia (serum creatinine >1.4 mg/dl) were observed
in 9 (52%) and 5 (29%) patients, respectively. Pleuritis (9 patients, 52%)
and arthritis (8 patients, 47%) were the most frequent clinical manifes-
tations. Oral ulcer and discoid rash (one patient each) were rarely
observed. Serum complement levels were reduced in all 17 patients.
FANA was positive in 16 (94%), anti-dsDNA was elevated in 10 (59%),
and thrombocytopenia was present in 10(59%) patients. The pathologic
findings showed diffuse proliferative lesions (WHO class IV) in 12(70%)
and diffuse membranous lesions (WHO class V) in 3 (17%) patients. The
renal function improved in 8 (47%), was stable in 2 (12%), deteriorated
in 4 (24%) patients, and one patient progressed to end-stage renal
disease.
Clinical and pathologic differences between membranoproliferative
glomerulonephritides caused by systemic lupus erythematosus and hepa-
titis B virus. Y.C, Jung, J.G. Lee, C. Ahn, J.S. Han, S. Kim, and J.S.
Lee, Department of Internal Medicine, Seoul National University
College of Medicine, Seoul, Korea. Hepatitis B virus-associated gb-
merulonephritis (HBGN) shows various pathologic findings. We have
classified them according to the WHO classification of lupus nephritis
(LN). The most common pathologic class in LN and HBGN is WHO
class IV, membranoproliferative glomerulonephritis (MPGN). We com-
pared clinical and pathologic findings between 46 LN and 54 HBGN
patients who were admitted to SNUH between 1981 and 1990. (1) Age
at the diagnosis was lower in the LN group (median 28.5 years) than in
the HBGN group (median 40.5 years). Male to female ratios were 4:43
for the LN group and 48:6 for the HBGN group. (2) Nephrotic
syndrome (NS) was observed more frequently in HBGN (26/53, 51%)
compared with LN (10/44, 23%). (3) Azotemia was more frequent in
HBGN (22/53, 42%) than in LN (7/43, 16%). (4) Under light microscopy
glomerular hypercellularity was more frequently observed in LN group
(90% vs. 63%), but the frequencies of segmental sclerosis, crescents,
tubular or interstitial changes were not significantly different. (5)
Capillary Clq deposits were found more frequently in LN (95%) than in
HBGN (63%); there were also more capillary and mesangial fibrinogen
deposits in HBGN than in LN. (6) On electron microscopic exam, the
frequencies of electron dense deposits according to the sites of depo-
sition were not different from each other. (7) The prognosis was better
for LN (remission in 14 and deterioration in 3 of 42) than HBGN
(remission in 0, deterioration in 13 of 43). In conclusion, considerable
clinical and pathological similarities were observed between lupus
MPGN and HB MPGN. The higher incidence of NS and azotemia with
poor prognosis in HBGN compared with LN was the major difference.
Endothelin in patients with lupus nephritis. J.L. Byun, G.B. Choi,
W.B. Pyun, and K.I. Yoon, Department of Internal Medicine, College
of Medicine, Ewha Womans University, Seoul, Korea. Endothelin is a
21-residue peptide vasoconstrictor produced by endothelium. The exact
role of endothelin in the pathophysiology of renal disease has not yet
been extensively demonstrated. Thus, we studied 7 patients diagnosed
as lupus nephritis by kidney biopsy and 7 healthy volunteers. Serum
and urine biochemical studies including creatinine, FDP D-dimer, NAG
and ET- 1, were done to investigate their potential role as a marker for
renal injury. The patient group and control group showed no significant
differences in their clinical characteristics, basic biochemical studies,
plasma ET-l concentration and ET-1 clearance rate. Of 7 lupus nephri-
tis patients, only 2 patients showed abnormal serum complement level
and anti-dsDNA level. In lupus nephritis patients, plasma ET-l level
showed no correlation with serum creatinine concentration, comple-
ment level and anti-dsDNA level. ET-l clearance rate also showed no
significant correlation with creatinine clearance rate, serum comple-
ment level, anti-dsDNA level and urinary NAG excretion. With the
above results, plasma ET-l level and its clearance rate could not reflect
the activity of lupus nephritis. Our study included a small number of
patients, and only 2 patients showed active disease, biochemically and
clinically. The majority of patients have already been in the remission
state alter treatment. The above factors probably acted as a bias against
the results leading to statistical limitations. So, prospective long-term
follow-up study is needed to further investigate the pathophysiological
role of ET-l in lupus nephritis.
Antineutrophil cytoplasmic autoantibodies (ANCA) in lupus nephritis
(LN). C.5. Lim, K.W. Joo, C. Ahn, J.S. Han, S. Kim, andJ.S. Lee,
Department of Internal Medicine, Seoul National University College of
Medicine, Seoul, Korea. ANCA is known to be helpful in the diagnosis
and evaluation of the disease activity in Wegener's granulomatosis.
ANCA is also detected in many other diseases, such as connective
tissue diseases, but its values in these diseases is not fully understood.
To evaluate the meanings of ANCA in LN, we performed ANCA test
by indirect immunofluorescence method in 22 LN patients, who were
admitted to the Seoul National University Hospital from November
1989 to March 1993. (1) All the patients were female except 1. The
pathologic classes of these patients according to the WHO classification
were class 1(1), class 11(1), class III (3), class IV (15), and class V (2).
(2) ANCA was positive in 11 patients (50%). Of them 8 showed
perinuclear type and 3 cytoplasmic type. (3) Anti-dsDNA level was
elevated more frequently in ANCA(+) patients (11/Il) than in
ANCA(—) patients (4/Il). There were no significant differences in the
incidence of LE cell, the pattern of FANA, the level of complement,
ESR, or the amount of 24-hour urine protein between the two groups.
(4) Among 11 ANCA(+) patients, 10 patients belonged to WHO class
IV and I patient to class III. ANCA was positive in 10/15 (66.7%) WHO
class IV patients. In conclusion, there was a positive correlation
between the positivity of ANCA and the level of anti-dsDNA, and a
high prevalence of ANCA among WHO class IV patients was found.
This suggests that ANCA could be a marker of disease activity and it
reflects the pathologic class of LN.
Erythropoietin concentration during end-stage renal disease on chronic
hemodialysis. Sae Yong Hong and Dong Ho Yang, Department of
Internal Medicine, Soonchunhyang University Chunan Hospital,
Chunan City, Choongnam Korea. A cross sectional study on erythro-
poietin with a retrospective review of medical records to evaluate the
relationship to the change in hematocrit, hemodialysis duration and
underlying disease was undertaken in fifty patients with end-stage renal
disease (ESRD) on hemodialysis. The EPO concentration of the ESRD
group (28.7 7.6 mU/ml) is about twice of normal pooled serum (12
mU/ml) and about one twentieth of control group (578.8 69.1 mU/mi).
There was a very wide range of distribution for EPO values in ESRD
ranging from 10.9 to 46.5 mU/mI. There is no relationship between the
EPO concentration and the underlying disease of ESRD except poly-
cystic kidney disease. However, the EPO concentration was lower in
the patients who underwent hemodialysis for a greater period of time.
EPO concentration was not influenced by the level of hematocrit and it
did not seem to influence the changes in hematocrit in ESRD. There
was no difference in EPO concentration between the transfusion group
and non-transfusion group. Our results suggest that the change in
hematocrit seen in ESRD is influenced by factors other than serum EPO
concentration.
Bone marrow changes following treatment of hemodialyzed patient
with erythropoietin. K.S. Yoon, J.H. Ahn, T, W. Lee, C.G. Ihm, and
M.J. Kim, Division of Nephrology, Department of Internal Medicine,
Kyung Hee University Hospital, Seoul, Korea. It has been documented
that recombinant human erythropoietin (rHuEPO) treatment could
correct anemia in most of the chronic hemodialyzed patients. To
evaluate the effect of rHuEPO on hemopoiesis, we investigated the
bone marrow cellularity and myeloid:erythroid ratio before and 3
months after rHuEPO treatment in chronic hemodialyzed patients. (1)
The Hb and Hct alter 3 months of rHuEPO treatment (10.1 0.8 gIdl,
30.5 2.1%) were significantly increased compared to those before
rHuEPO treatment (6.4 0.5 g/dl, 20.1 1.5%; each P < 0.005). (2)
Before rHuEPO treatment, the bone marrow findings showed hypocel-
lular marrow and decreased erythropoiesis in 8 out of 10 patients. (3)
The bone marrow cellularity after 3 months of rHuEPO treatment (37.5
13.3%) was significantly increased compared to that before rHuEPO
treatment (28.5 10.0%; P < 0.005). (4) The myeloid:erythroid ratio
alter 3 months of rHuEPO treatment (2.4 1.05:1) was significantly
decreased compared to that before rHuEPO (4.0 1.17:1; P <0.005).
In conclusion, these data suggest that most of the chronic hemodialyzed
patients may have hypocellular marrow and decreased erythropoiesis,
which can be improved by short-term rHuEPO treatment.
The effect of recombinant human growth hormone on the growth in the
children with chronic renal failure. S. W. Yang, 1'. Choi, and H.R.
Moon, Department of Pediatrics, Seoul National University College of
Medicine, Seoul, Korea. We studied the effect of rhGH on the growth
in seven children with chronic renal failure (CRF). All seven children
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showed normal GH responses (peak GH response, more than 10 ng/ml)
to classical GH provocative tests (L-dopa, Arginine), and these results
did not differ from that of healthy children. The change of height SDS
for 1 year of rhGH treatment was from —3.47 1.31 to —2.74 1.56,
which had no statistical significance (P > 0.1). The growth velocity
during 1 year prior to and following rhGH treatment increased from 2.78
0.85 cm/year to 11.24 7.90 cm/year, respectively, which had
statistical significance (P < 0.05). One child who had had successful
renal transplantation showed an increase in the height SDS from —5.4
to —4.0 and an increase in the growth velocity from 3.2 cm/year to 12.2
cm/year with rhGH treatment. The predicted adult height, obtained by
Tanner-Whitehouse method, following GH treatment increased from
151.9 5.7 cm to 160.4 10.3 cm, which had marginal statistical
significance (P = 0.05). Subcutaneous fat mass, measured with triceps
subcutaneous skin fold, decreased significantly with significant increase
in muscle mass following rhGH treatment (P < 0.05). Through the
period of rhGH treatment, we could not observe any side effect of GH
treatment, such as hypothyroidism, glucose intolerance, or aggravation
of renal function. Also, we could not observe any exaggerated advance-
ment of bone maturation (0.6 0.2 year/chronological year) during
rhGH treatment, rather less than the advancement of chronological age.
"Tc-HSA cardiac gated blood pool scan (GBPS) in patients with
end-stage rena! failure. K.W. Lee, S.S. Kim, M.S. Jeong, S.K. Rhee,
Y.T. Shin, and H.K. Ro, Department of Internal Medicine, College of
Medicine, Chungnam National University Hospital, Daejeon, Korea.
Congestive heart failure is a common and serious problem in patients
with chronic renal failure (CRF) and many cardiovascular deaths of
these individuals have been attributed to myocardial dysfunction.
ssmTccardiac gated blood pool scan (GBPS) is a noninvasive method
for examining cardiac function. And various functional indices such as
left ventricular ejection fraction (LVEF), peak ejection rate (PER), and
peak filling rate (PFR) are available. Among them, PFR is known as the
diastolic left ventricular functional index which early discloses func-
tional derangement of left ventricle in patients with coronary artery
disease and cardiomyopathy. To evaluate left ventricular function in
patients with CRF, we performed mTcHSA cardiac gated blood pool
scan in 31 normal controls and 82 patients with CRF admitted to CNUH
from August 1991 to March 1993. The patients with coronary artery
disease or primary valvular heart disease were excluded. Forty-five
(group A) of 85 patients were not being managed by renal replacement
therapy. Seventeen patients (group B) were managed by hemodialysis
for a period of less than one month. And twenty patients (group C) were
managed by hemodialysis for a period of more than one month. We
compared various LV functional indices of GBPS with clinical param-
eters of patients with CRF. Mean left ventricular ejection fractions
(LVEF) in groups A and B were 51 and 49%, respectively. And those
were significantly lower than 61% in the normal control group (P <
0.05, P < 0.05 respectively). However, LVEF (56%) in group C is not
significantly different from the control group. Mean peak ejection rates
(PER) in groups A and B were 3.04 and 2.99, and significantly lower
than the 3.56 of the control groups. Mean peak filling rates (PFR) of
group A, B and C patients were 2.4, 2.4, and 2.78, respectively. All of
them were significantly lower than the 3.42 of control groups (P <
0.001, P < 0.01, P < 0.05, respectively). Blood pressure, hematocrit
and serum levels of electrolyte, BUN, creatinine, lipids and uric acid of
the patients with decreased left ventricular function were not signifi-
cantly different from patients with normal left ventricular function.
LVEF, PER and PFR in 32 patients (39%) with diabetic nephropathy
induced end-stage renal failure were not different from those of patients
with non-diabetic end-stage renal failure.
Changes of the levels of blood glutathione and RBC antioxidant
activities in patients with chronic renal failure. H.S. Lim, J.H. Chung,
and C.O. Moon, Department of Nephrology, Chosun University Hos-
pital, Kwangju, Korea. Background: The development of uremic symp-
toms in patients with chronic renal failure is related to the decreased
RBC antioxidant activities. We performed this study to observe the
degree of blood glutathione synthesis in patients with chronic renal
failure, and to investigate the relationship between the levels of blood
glutathione and the enzyme activities of antioxidants. Methods: The
levels of blood glutathione, RBC antioxidants (such as, superoxide
dismutase, catalase) and glutathione related enzymes activities were
examined in twenty-one patients with chronic renal failure undergoing
maintenance hemodialysis on two to three day intervals (CRF group)
and fifteen normal patients (control group). Results: The levels of total
blood glutathione were significantly decreased in the CRF group and the
levels of blood reduced glutathione (GSH) have decreased compared to
control group, but the alteration of red blood cell (RBC) SOD, catalase
and glutathione peroxidase activities was not statistically significant.
Glutathione S-transferase (one of the glutathione related enzymes)
activity was significantly increased in the CRF group, but the other
enzymes of those were not significantly different. Conclusions: These
results suggest that the decreased levels of blood total glutathione and
reduced glutathione due to the decreased glutathione synthesis and
increased utilization of reduced glutathione, probably contribute to
increased peroxidative damage to cells in patients with chronic renal
failure.
The survival rate and causes of death in patients with chronic renal
failure on hemodialysis. J.H. Kim, K. W. Kahng, J.H. Kim, Hi. Kim,
C.H. Park, C.M. Kang, and H.C. Park, Department of Nephrology,
Hanyang University Hospital, Seoul, Korea. Regular hemodialysis has
been established as a way of treatment for end-stage renal failure. There
are many reports on long-term follow-up for chronic hemodialysis
patients. We analyzed the patients with chronic renal failure on
hemodialysis. In a retrospective study, the survival rate and the causes
of death were analyzed in 548 patients with chronic renal failure on
hemodialysis during the period of 1982 to 1991, treated at the Hanyang
University Hospital. The patients were mostly dialyzed 2 to 3 times a
week for 4 to 5 hours. These patients' male to female ratio was 58:12
and the mean age was 47.2 13.7 years. Underlying disorders of
chronic renal failure consisted of mainly chronic glomerulonephritis
(23.5%), followed by diabetic nephropathy (15.9%), and hypertensive
nephrosclerosis (13.9%). The causes of death were most frequently
cerebrovascular accidents (25.9%), including hemorrhage and infarc-
tion, followed by cardiac disorders (19.4%), infections (16.7%), and
gastrointestinal bleedings (6.5%). The overall of survival rates in
hemodialysis patients were 85.6% for 1 year, 75.3% for 2 years, 62.3%
for 5 years, and 33.7% for 10 years. Dividing into subgroups, renal
failure due to diabetes and hypertensive nephrosclerosis carried signif-
icantly poor outcomes. The survival rate of the older patients was less
than that of younger patients (P < 0.001). We should pay attention to
the hemodialysis patients during the first year because survival rates
during this period were less than during other periods.
Clinical application of urea kinetic modeling (UKM). G.B. Choi, S.A.
Jung, Y.S. Hong, and K.I. Yoon, Department of Nephrology, Ewha
Womans University Hospital, Seoul, Korea. To evaluate the adequacy
of hemodialysis, Ks/V urea is quantitatively used as a guideline for
dialysis prescription. After UKM of 22 patients undergoing regular
hemodialysis (12 males, 10 females) by TherApsTM program of Cobe
laboratories, we performed dialysis prescription and evaluated its
adequacy. The Ks/V urea was calculated by percent reduction of urea
(PRU) (PRU-K/V) and compared with Ks/V urea by UKM (UKM-K/
V). Profile 1 includes urea distribution volume (UKM vol) and KfV
urea. In addition, protein catabolic rate (PCR) is also included in profile
2. When the difference (Vol-Dev) between UKM volume and anthro-
pometric volume exceeded the acceptable range (—15% — + 15%),
correction was made. If corrected, profile 2 was calculated. But if not,
only profile I was calculated. According to the method of profile
composition for dialysis prescription, two uncorrected profile 2 was
used in Group 1, two profile 2 including corrected proffle 2 in Group 2,
and profile I and 2 in Group 3. (1) Among 44 cases of UKM, Vol-Dev
exceeded the acceptable range in 21 cases (48%), and 11 cases of them
(52%) were corrected. (2) Uncorrected cases and corrected cases
showed no significant differences in (UKM-K/V)/(PRU-K/V) ratio. (3)
Corrected and uncorrected group showed highly significant positive
correlation between UKM-K1/V and PRU-K/V (r = 0.95 and r = 0.98;P < 0.00, 2-tail prob.). (4) Between in vivo clearance and effective
clearance, the uncorrected group showed a positive correlation (r =
0.94,P <0.00), but the corrected group did not. (2-tail prob.). (5) There
are no significant differences in Ks/V urea deviation, pre- and post-BUN
deviation from prescribed value between three groups; and pre- and
post-BUN and Kr/V urea have no significant differences between
measured and prescribed value in each group. (6) In 10 cases of UKM
after prescription, there were positive correlations between pre-BUN
deviation and PCR deviation, between post-BUN deviation and PCR
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deviation, and between pre-BUN and post-BUN deviation from pre-
scribed value. (1-tail prob.) In conclusion, there are few influences on
the adequacy of dialysis prescription, whether Vol-Dev is corrected or
not. The frequency of the tests can be lessened and prescription made
more easily with Vol-Dev correction.
Factors influencing fistula survival in chronic hemodialysis patients.
Y.S. Kim, Y.S. Shin, E.H. Im, S.A. Yoon, D.C. fin, Y.S. Yoon, and
B.K. Bang, Department of Internal Medicine, Catholic University
Medical College, Seoul, Korea. Recently, the prevalence of diabetes
has tended to increase in patients on hemodialysis. These patients often
require prosthetic fistulas for vascular access. The fistula survival in 172
patients receiving hemodialysis at our center between 1982 and 1992
was studied in view of sex, age, presence of diabetes, and type of
access. Two hundred nine fistulas were placed in 144 nondiabetic
patients and 48 in 28 diabetic patients. In all patients fistula survival was
74% at 1 year, 61% at 2 years, and 34% at 5 years. There were no
differences in fistula survival according to sex. The fistula survival was
95% at 1 year, 88% at 2 years, and 73% at 3 years in patients aged below
30 years; 73% at 1 year, 63% at 2 years, and 53% at 3 years in patients
aged between 30 years and 50 years; 62% at 1 year, 44% at 2 years, and
29% at 3 years in patients aged over 50 years. The fistula survivals of the
three groups of patients by age were comparable (P < 0.001), The mean
follow-up time between nondiabetic and diabetic patients was not
different (18 months vs. 13 months) and mean time to loss of fistula was
longer in nondiabetic (25 28 months) than that in diabetic patients (11
10 months) (P < 0.05). The fistula survival of nondiabetic patients
was significantly higher than that of diabetic patients (79% vs. 56% at 1
year; 66% vs. 45% at 2 years; and 55% vs. 19% at 3 years) (P < 0.001).
The fistula survival with native vessel was significantly higher than
prosthetic fistula survival (79% vs. 59% at 1 year; 72% vs. 37% at 2
years; and 63% vs. 19% at 3 years) (P < 0.0001). These findings
demonstrate that fistula loss occurs earlier in prosthetic fistula com-
pared with fistula with native vessel, in diabetic compared with nondi-
abetic patients, and in older age at placement.
Serum lipoprotein(a) and dyslipidemia in patients with chronic renal
failure receiving hemodialysis. H.S. Cho, K.S. Lee, S. 1'. Nam, H.S.
Kim, S.K. Ha, H. Y. Lee, D.S. Han, and J.H. Kim, Departments of
Internal Medicine and Clinical Pathology, Yonsei University College of
Medicine, Seoul, Korea. Lipoprotein(a) (Lp(a)) is an LDL-like particle
with a large glycoprotein called apolipoprotein(a) attached to its apo
B-100 through disulfied bond. Lp(a) has recently been recognized to be
a risk factor for coronary heart disease. The reasons for the association
between Lp(a) and coronary heart disease are its physical characteris-
tics and evolutionary homology with plasminogen, but little is known
about the Lp(a) level and its clinical significance in patients with chronic
renal failure undergoing long-term dialysis who are at increased risk for
coronary heart disease. We have studied Lp(a) and lipid profile in 70
chronic renal failure patients receiving hemodialysis and 58 control
subjects. Age distribution was similar in two groups. Weight and body
mass index were not different in the two groups. Percent ideal body
weight (PIBW) was higher in control subjects compared with hemodi-
alysis patients. Hemodialysis patients were more likely to be male than
were control subjects. Triglyceride concentrations were higher and
total cholesterol, LDL cholesterol and HDL cholesterol concentrations
were lower in hemodialysis patients compared with control subjects.
Mean and median Lp(a) concentrations (in mg/dl) were higher in
hemodialysis patients compared with controls (25.3 1.7, 16.0 vs. 11.5
1.7, 6.0; mean SE, median). Correlation analyses were performed
between Lp(a) concentrations and other variables in the hemodialysis
group. BUN, total and LDL cholesterol and apo B showed a highly
significant relationship, and age, weight, BMI, PIBW, creatinine,
triglyceride, HDL cholesterol and apo Al showed no relationship to
serum Lp(a) levels in chronic renal failure patients receiving hemodi-
alysis. These results indicate that Lp(a) levels are increased in chronic
renal failure and may increase the risk for coronary artery disease in
these subjects.
in vivo and in vitro induction of IL-i, TNF, and IL-6 during hemodi-
alysis. J.H. Ahn, Y.H. Kim, J.K. Park, T.W. Lee, C.G. Ihm, and M.J.
Kim, Division of Nephrology, Department of Internal Medicine, Kyung
Hee University Hospital, Seoul, Korea. To evaluate the role of the
cytokines in the inflammatory response induced by blood interaction
with hemodialysis membranes, we have investigated the IL-i, TNF and
IL-6 concentrations of the plasma and in the supernatant of 24 hour
cultured peripheral blood mononuclear cells (PBMC) isolated from: (a)
9 hemodialyzed patients with recombinant human erythropoietin
(rHuEPO) (Group 1); (b) 9 hemodialyzed patients without rHuEPO
(Group 2); (c) 7 patients with advanced chronic renal failure (Group 3);
(d) 8 healthy control subjects (Group 4). In hemodialyzed patients with
rHuEPO, the blood samples were drawn pre- and post-dialysis using the
following criteria: (1) last dialysis with PMMA membranes (HDEI); (2)
after two weeks of dialysis with cuprophane membranes (HDE2); (3)
after two further weeks of dialysis with PMMA membranes (HDE3). In
plasma concentrations, IL-I levels in Group 1 (45.32 2.63 fmol/ml)
and Group 2(42.05 1.93 fmollml) were significantly high compared to
that of Group 4 (33.81 2.38 fmollml; P < 0.05). IL-I level in
pre-HDE3 (40.21 3.16 fmol/ml) was significantly low compared to
those of pre-HDE1 (45.32 2.63 fmol/ml; P < 0.01) and pre-HDE2
(43.74 3.57 fmollml; P < 0.05). In the supernatant of cultured PBMC,
IL-i levels in pre-HDE2 (29.77 6.18 fmollml) and pre-HDE3 (25.36
3.53 fmollml) were significantly low compared to that of HDEI (46.88
7.33 fmol/ml; each P < 0.05). IL-6 level in pre-HDE3 (264.8 60.8
fmol/ml) was significantly low compared to pre-HDE1 (604.0 78.5
fmollml; P < 0.05). These results suggest that IL-l, TNF and IL-6 are
induced by blood interaction with dialysis membranes during chronic
hemodialysis, and the synthesis and release of these cytokines in
cultured PBMC may be induced by long-term stimulation with hemo-
dialysis membranes.
IL-i, TNF and IL-6 production by peripheral blood mononuclear cells
in different hemodialysis membranes. J.H. Ahn, Y.H. Kim, J.K. Park,
1'. W. Lee, C.G. Ihm, and M.J. Kim, Division of Nephrology, Depart-
ment of Internal Medicine, Kyung Hee University Hospital, Seoul,
Korea. To evaluate the effects of hemodialysis membranes on the
cytokine production by peripheral blood mononuclear cells (PBMC),
we investigated the IL- 1, TNF and IL-6 concentrations in the superna-
tant of 24 hour cultured PBMC without (spontaneous group) or with
broken cuprophane or PMMA membranes in chronic hemodialyzed
patients. The blood samples were drawn pre-dialysis using the following
criteria: (a) last dialysis with PMMA membranes (HDE1); (2) after two
weeks of dialysis with cuprophane membranes (HDE2). The control
samples were obtained from 8 healthy subjects. In HDE1, IL-i and IL-6
levels of PMMA group (68.72 14.06, 901.9 179.2 fmol/ml) were
significantly high compared to those of the spontaneous group (41.17
8.15, 616.1 101.8 fmol/mI; each P < 0.05), TNF level of the
cuprophane group (70.39 13.54 fmol/ml) tended to be high compared
to that of the spontaneous group (45.28 9.81 fmol/ml; P = 0.058). In
HDE2, IL-i, TNF, and IL-6 levels of cuprophane and PMMA groups
were significantly high compared to those of the spontaneous group
(each P < 0.05). In control subjects, IL-6 levels of the cuprophane
group (904.8 148.2 fmollml), and PMMA group (1039.4 178.1
fmol/ml) were significantly high compared to that of spontaneous group
(768.9 152.3 fmol/ml; each P < 0.05). There were significant corre-
lations between IL-l and TNF (r = 0.55, P < 0.001), between IL-i and
IL-6 (r = 0.74, P < 0.001), and between TNF and IL-6 (r = 0.59, P <
0.001). These data suggest that the interaction of cuprophane or PMMA
membranes with PBMC stimulates the production of IL-l, TNF and
IL-6, and PBMC dialyzed with cuprophane membrane may have more
pre-activation states for cytokine production than that with PMMA.
Effects of different dialysis membranes on platelet activation and
fibrinolysis during hemodialysis. Y.H. Lee, Y.J. Kwon, H.-J. Pyo, S.
Kim, andJ.S. Lee, Department of internal Medicine, Korea University
Hospital and Seoul National University Hospital, Seoul, Korea. The
biocompatibility of dialysis membranes can be assessed by several
ways, including complement activation and the degree of leukopenia.
The activation of platelet and fibrinolytic system can also be used as an
index of biocompatibility. Therefore, we investigated the serial changes
of the platelet count, platelet aggregate ratio (PAR) and plasma
p-thromboglobulin (13-TG) during hemodialysis using two different
kinds of membrane (PMMA and cuprophane). We also measured the
plasma concentration of fibrinolytic proteins such as antithrombin III
(AT III), a2-plasmin inhibitor (a2-PI) and plasminogen (PLG) during
hemodialysis at 0, 30, 60, 120 and 180 minutes. (1) Platelet count was
significantly decreased at 30 minutes (P < 0.05) and recovered after 60
minutes of hemodialysis in both types of membrane, PAR increased
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significantly at 120 minutes and plasma 13-TG was continuously in-
creased in both membranes (P < 0.005). (2) The concentrations of AT
111(180 mm) and a2-PI (30 and 60 mm) were significantly decreased only
in cuprophane hemodialysis, and there were no significant changes in
PMMA dialysis. The concentrations of plasma PLG showed no signif-
icant changes during hemodialysis in both types of membrane. From the
above observations, we conclude that PMMA membrane causes less
alteration in fibrinolytic proteins during hemodialysis than cuprophane
membrane.
Anti-hepatitis C virus positivity in hemodialyzed patients. G.C. Kwak,
J.S. Song, C.H. Kim, E.T. Kang, andS.H. Yu, Department of Internal
Medicine, College of Medicine, Chung-Ang University, Seoul, Korea.
The infection by hepatitis C virus is a serious problem in dialysis
centers, not only for its high prevalence, but especially for the uncer-
tainty of the mode of transmission of the virus among the long-term
hemodialyzed patients. To evaluate the mode of viral transmission, we
studied its correlation with blood transfusion and other factors. Forty-
six patients on regular hemodialysis therapy between January 1984 and
March 1993 at our hospital were enrolled in this study. There were 28
males and 18 females (mean age 50 years in men, 55 years in women).
HCV antibodies were detected by second (EIA) generation anti-HCV
assays (Abbott Diagnostics, North Chicago, Illinois, USA). (1) HCV
antibodies were present in 22 of 46 patients (47.8%, 13 male and 9
female). (2) A mean of 10 pints of blood was transfused in HCV-positive
subjects and 4 pints of blood transfused in HCV-negative subjects (P =
0.01671). (3) The mean duration of hemodialysis was 51 months in
HCV-positive subjects and 17 months in HCV-negative subjects (P =
0.0001). (4) The frequency and total time (hours) of the hemodialysis
were increased in HCV-positive subjects versus in HCV-negative
subjects (302±22.81 vs. 133 l76.3,P=0.007l; 1567± 1071.9vs. 669
881.8, P = 0.003). (5) AST and ALT were significantly elevated
during anti-HCV positive seroconversion in HCV-positive subjects (49
55.5 vs. 21 17.9, P = 0.0384; 84 124.8 vs. 23 19.5, P = 0.0278).
In conclusion, there was no correlation between blood transfusion and
HCV positivity, but was there was a statistically significant correlation
with the frequency and total time of the hemodialysis, particularly with
hemodialysis duration. Therefore, this suggests there might be another
mode of transmission of HCV, environmental factors being somewhat
different from that of hepatitis B virus.
The prevalence of hepatitis C virus antibodies in patients treated with
hemodialysis and continuous ambulatory perltoneal dialysis. D.H. Kang,
J.A. Kim, C.S. Park, K.Y. Kim, H.S. Kim, H.Y. Lee, andD.S. Han,
Department of Nephrology, Yonsei University Hospital, Seoul, Korea.
We determined the prevalence of antibodies to the hepatitis C virus
(anti-HCV) in 54 hemodialysis (HD) patients and 241 continuous
ambulatory peritoneal dialysis (CAPD) patients, using a recombinant
enzyme immunoassay test (Abbot Labs). The mean age for HD patients
and CAPD patients was 48.4 14.0 (mean SD) and 46.6 13.8 years,
respectively. Fifteen patients (27.8%) were anti-HCV (+) among the
HD group, and twelve patients (5.3%) were anti-HCV(+) among the
CAPD group. The prevalence of anti-HCV was significantly greater
among the HD group than in the CAPD group (P < 0.05). In the HD
group, the positivity of anti-HCV correlated with the duration of HD,
but there was no significant correlation with the history of transfusion,
the amount of transfusion, and abnormal alanine aminotransferase
(ALT). However, in the CAPD group, there was no significant corre-
lation between anti-HCV and the history of previous hemodialysis,
duration of CAPD, the amount of transfusion, and abnormal ALT level.
Three of the 15 anti-HCV positive patients were noted to have an
elevation in the serum ALT level in the HD group, but there was no
significant correlation between the level of ALT and anti-HCV. During
follow-up since July 1992, we noted 3 cases of seroconversion of
anti-HCV. One CAPD case showed negative conversion from positive
and the other two HD cases converted positive from negative anti-
HCV. There were no significant changes of liver function during the
follow-up period in these cases. In conclusion, the prevalence of
anti—HCV was significantly higher in HD patients compared to CAPD
patients, and the positivity for anti-HCV in HD patients correlated with
the duration of HD. From the above results, we recommend regular
follow-up of anti-HCV and isolation of anti-HCV(+) HD patients with
separate machines to prevent the transmission of hepatitis C virus
during hemodialysis.
Effects of continuous intestinal dialysis (CID) for chronic uremia by
oral non-absorbable mannitol solutions (NAMS). I. Y. Hwang, G.H. Kim,
P.J. Jung, J. 1'. Ham, and D.S. Shim, Division of Nephrology, Depart-
ment of Internal Medicine, Gyung-Sang University Hospital, Jinju,
Korea. The present study deals with the therapeutic effects of CID by
oral NAMS in chronic uremic patients. CID was carried out in 27
chronic uremic patients who had creatinine clearance of 6.48 3.67
mI/mm and drank 200—250 ml NAMS every six hours for 2 to 6 months.
Blood urea nitrogen (BUN), serum creatinine (Sr), serum phosphorus
(Sp), and serum uric acid (Sua) before CID were 84.40 32.68, 10.97
3.64, 6.22 1.79, 9.04 3.14 mg/dl, respectively. During the 2 months
after CID, BUN, Sr, Sp and Sua were significantly lowered to 62.95
25.14, 9.59 3.40, 5.17 1.67, and 8.00 2.66 mg/dl in chronic uremic
patients compared to before CID (P < 0.05). In 9 of the 27 chronic
uremic patients who stopped the CID by themselves for 2 weeks, BUN,
Scr, Sp, and Suaincreasedto 107.33 38.75, 12.63 3.30, 6.78 4.23,
8.93 5.69 mgldl compared to the CID patients (P < 0.05). We applied
the high performance gel chromatography for the chronic uremic
patients before and after CID, Integrated absorbance of 3 peaks which
corresponds to middle molecule range (less than 1500 daltons) was
significantly decreased during CID when compared to the peaks before
CID (P < 0.05). There were no significant changes in body weight,
serum calcium, serum sodium, serum potassium, serum chloride,
hemoglobin, hematocrit and RBC (P > 0.05). From these clinical
results, CID by oral NAMS can be well-tolerated, remove the uremic
toxins, improve uremic symptoms, and could be a new approach to the
replacement therapy of chronic uremic patients.
K/V and clinical outcome in CAPD. H.B. Lee, D.C. Han, H.K. Cha,
S.H. Chung, S.K. Lee, S.D. Hwang, and C. Moon, Hyonam Kidney
Laboratory, Soon Chun Hyang University, Seoul, Korea. In order to
examine if K/V can predict clinical outcomes (death, transfer to HD
and hospital admission), we performed univariate and multivariate
analysis on 10 metric variables, including K/V and 2 categorical
variables generated from one year follow-up of 31 CAPD patients (age
46.9 13.0 years, 23% diabetics, duration of CAPD before study 29.5
20.1 months). Five patients died, 6 transferred to HD, and 21 had
hospital admissions during the follow-up. On univariate analysis there
were significant differences in serum creatinine, albumin, age, clinical
assessment score and co-morbidity score (diabetes, hypertension and
history of MI and/or stroke) between those dead and alive, There were
no differences in Kt/Vure, Kt/Vcr, NPCR, (Kt+Kr)Cr x 7/1.73 m2,
BUN, duration of CAPD and dialysis index between the dead and
survivors. There were no differences in any variable between those
remaining on CAPD and those transferred to UD and between those
admitted to hospital and those not. Death discriminant analysis on 10
metric variables revealed that serum albumin was a powerful negative
predictor and age and NPCR were weaker positive predictors of death
(P < 0.01, 92.3% accurate). On stepwise variable selection, serum
albumin was also a powerful negative predictor of hospitalization (P =
0.008) and was correlated with serum creatinine (P = 0.005) and
Kt/Vurea (P = 0.008). In conclusion, serum albumin was a powerful
negative predictor of death and hospital admission. Age was a weaker
predictor of death. None of the variables predicted transfer to HD.
Although Kt/Vurea was correlated with serum albumin, it failed to
predict clinical outcomes.
Plasma and RBC amino acid profile in CAPD. S.D. Hwang, D.C. Han,
5K. Lee, J.K. Kim, S. Y. Kim, M.S. Park, S.J. Lee, and H.B. Lee,
Hyonam Kidney Laboratory, Soon Chun Hyang University and Bo-
ryung Pharmaceutical Company, Seoul, Korea. The prevalence of
malnutrition is high in CAPD, and important catabolic factors include
poor dietary intake, insufficient dialysis of small solutes, dialytic losses
of proteins and amino acid (AA) and catabolic events, such as perito-
nitis. In order to assess the AA profile during dialysis, we measured
plasma and RBC AA concentrations in 11 CAPD patients (duration of
CAPD 34.6 28.8 months) and 11 hemodialysis (HD) patients (duration
of HD 23.9 22.9 months), and the results were compared to those of
12 healthy controls (HC). We also measured AA concentration in
drained dialysate and calculated peritoneal AA clearance and daily
dialysate loss of AA. The plasma concentrations of all essential AA,
except for arginine, were low in CAPD and all but arginine, phenylala-
nine and histidine were also low in HD. Among 10 nonessential AA
studied, the plasma levels of serine and tyrosine were low and glycmne
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high in both CAPD and HD. Citrulline and cysteine were high in plasma
of HD but not in CAPD. The RBC concentrations of isoleucine, leucine
and threonine were significantly lower in HD but not in CAPD; valine
was significantly lower in both CAPD and HD; arginine was signifi-
cantly higher in CAPD than in HC. The RBC concentrations of
ornithine, proline and glycine were high in both CAPD and HD; GABA
and taurine were high in CAPD only. Asparagine was low in RBC in HD
only. Pentoneal clearance was 4.47 0.41 mI/mm (3.88—5.19) for 9
essential AA and 4.89 2.43 mI/mm (2.72—12.81) for 15 non-essential
AA. Total daily dialytic loss was 573.92 mg for 9 essential AA and
1110.7 mg for 15 non-essential AA. Both CAPD and HD are associated
with significant decreases in plasma and RBC concentrations of many
essential AA. The concentrations of some nonessential AA are in-
creased in both CAPD and HD. These abnormalities may reflect poor
intake, dialysate loss and abnormal renal metabolism in dialysis pa-
tients.
Nonoperative technique in catheter malfunction in CAPD. J. W. Lim,
S. Cho, J.H. Bang, D.H. Kim, S.H. Kim, and D.K. Cho, Department
of Nephrology, Kyungpook National University Hospital, Taegu, Ko-
rea. Peritonitis and peritoneal catheter malfunction remain the two
most common causes for failure of chronic peritoneal dialysis. Exten-
sive quantitative data on the nonoperative technique alternative to
surgical placement of a new catheter in catheter malfunction due to
dislodgment and obstruction are not available. From January 1991
through February 1993, 15 adult patients developed catheter malfunc-
tion due to dislodgment and obstruction. Thirteen fluoroscopic guided
brushings and twelve laparoscopic guided manipulations were per-
formed on those patients in an effort to prolong catheter life. Four
patients developed catheter malfunction by omental wrapping with
secondary migration, four patients by fibrin deposits or blood clots, and
seven patients by dislodgment and obstruction. Four patients restored
catheter function by fluoroscopic guided brushing, four patients by
laparoscopic guided manipulations, two patients by laparoscopy fol-
lowed by fluoroscopy, and one patient by fluoroscopy followed by
laparoscopy. However, the remaining four patients, even after repeated
manipulations, had catheters removed due to persistent malfunction.
Eight patients were immediately successful at the time of the proce-
dure, two patients successful in the first week, one patient in the third
week. There were two complications attributed to the procedure: one
was dialysis solution leak around the laparoscopy insertion site which
was recovered by resting for two weeks, and the other was a broken
catheter tip within the peritoneum which could be removed safely by
laparoscopy. In conclusion, fluoroscopic or laparoscopic guided manip-
ulation of catheter is a useful and safe technique in the catheter
malfunction, and can also be a desirable alternative to surgical place-
ment of a new catheter.
Clinical review of fungal peritonitis in patients on continuous ambula-
tory peritoneal dialysis (CAPD). J. V. Cho, C.S. Park, K. V. Kim, H.S.
Kim, H. V. Lee, and D.S. Han, Department of Internal Medicine,
Yonsei University College of Medicine, Seoul, Korea. CAPD peritonitis
is one of the most important complications of peritoneal dialysis.
Among the CAPD peritonitis fungal peritonitis is relatively rare com-
pared to bacterial peritonitis, but the prognosis is more poor; for
treatment, removal of the peritoneal catheter is essential. We report our
center's experience with 21 episodes of fungal peritonitis confirmed by
CAPD effluent fluid culture, that occurred from January 1983 to March
1993. The male to female ratio, the mean age, and the mean duration of
CAPD were 11:10,48.2 11.2 years (range 17—70), 21.0 20.8 months
(1—72), respectively, and the mean annual incidence of peritonitis was
1.47 1.49(0—4). The underlying renal diseases were diabetic nephrop-
athy 6 cases (29%), chronic glomerulonephritis 5 cases (24%), hyper-
tensive nephrosclerosis 3 cases (14%), lupus nephritis 2 cases (9%) and
unknown causes 5 cases (24%). The symptoms of peritonitis were
abdominal pain 19 cases (90%), fever 4 cases (20%), and the mean
CAPD effluent WBC counts were 1176.6 1032.6/mm3 (156—4149). The
most common causative fungi were candida species 86% (N 18), and
in the remaining 3 cases Trichosporon beigelii, Mucormycosis species,
and Cryptococcus neoformans were isolated, respectively. Eighteen
cases were treated medically by catheter removal alone (N = 6), or by
catheter removal followed by intravenous antifungal (amphotericine B)
agent (N = 12). The other 3 cases who were complicated with
intraabdominal abscess and intestinal obstruction were treated success-
fully by surgical drainage in 2 cases and by ultrasound guided pig tail
catheter insertion into the abscess cavity in 1 case. The complications
were: intraabdominal abscess combined with intestinal obstruction 3
cases (14%), sepsis 2 cases (10% bactenal, candidial 5%, respectively),
partial intestinal obstruction 1 case (5%), and meningitis I case (5%).
Three cases (14%) of mortality were noted during the treatment and the
causes of death were sepsis 2 cases, and progressing pneumonia 1 case.
In conclusion, among 21 cases of CAPD fungal peritonitis, 18 cases
were treated successfully by medical therapy alone, but the remaining
3 cases who were complicated with intraabdominal abscess with
intestinal obstruction needed surgical or catheter drainage of intraab-
dominal abscess for successful treatment.
Gram-negative peritonitis associated with continuous ambulatory pen-
toneal dialysis. S.B. Park, H. V. Byun, S.S. Cho, S.H. Lee, and H.C.
Kim, Department of Internal Medicine, Keimyung University School of
Medicine, Taegu, Korea. We experienced 56 episodes of CAPD peri-
tonitis caused by gram-negative organism, which accounted for 22.4%
of all episodes of peritonitis at Keimyung University Hospital from 1988
to 1992. Among the gram-negative organisms, Pseudomonas species
(23.2%) were most common, but Acinetobacter species (21.4%) were
nearly as frequent. The remaining common gram-negative bacterial
isolates were E. coli (17.8%), Enterobacter (12.5%) and Serratia (7.1%)
species. Abdominal pain, cloudy dialysate and increased number of
WEC count in dialysate were found in all cases, abdominal tenderness
in 87%, rebound tenderness in 46.4%, fever in 33.9%, nausea in 21.4%,
and vomiting in 7.8%. Catheters had to be removed in 55.4% (31 of 56)
of gram-negative peritonitis. It was necessary to remove the catheter in
all cases caused by Serratia, Proteus, Achromobacter and Salmonella,
in 69.2% by Pseudomonas species, in 50% by E. coli, Acinetobacter,
Citrobacter and Providencia, and in 25% by Enterobacter. However,
treatment with intraperitoneal antibiotics was successful in all cases of
peritonitis caused by Kiebsiella and Flavobacterium. Among 31 pa-
tients who required catheter removal, two patients underwent laparot-
omy due to intraabdominal abscess formation and adhesion, and there
were nine deaths related to gram-negative peritonitis. It is concluded
that early catheter removal is necessary in gram-negative peritonitis,
particularly if caused by Serratia, Proteus, Achromobacter, Salmonella
and Pseudomonas species.
Multifocal accumulation on peritoneoscintigraphy (FSG) in CAPD
patients: A poor prognostic sign in CAPD. J.H. Bang, S. Cho, D.H.
Kim, J. W. Lim, S.H. Kim, and D.K. Cho, Department of Nephrology,
Kyungpook National University Hospital, Taegu, Korea. Multifocal
accumulation of sulfcolloid on PSG could be seen in patients with
recurrent peritonitis episodes and was reported as the result of inade-
quate intermesenteric drainage of dialysate or increased lymphatic
absorption of radiocolloid activity. These patients showed decreased
radiocolloid recovery and poor ultrafiltration. From July 1989 through
March 1993, 83 adult patients with CAPD therapy underwent PSG and
six patients presented with multifocal accumulation of radiocolloid on
PSG. Six patients with end-stage renal disease undergoing CAPD
consisted of all males aged 18—63 years (mean 44.8). The underlying
diseases of chronic renal failure were chronic glomerulonephritis in 3,
hypertension in 2, and Takayasu's arteritis in 1 patient. All patients had
peritonitis, but only two patients had recurrent peritonitis. They
showed a dramatic decrease in percentage of recovery of sulfcolloid
from the peritoneal cavity (mean 29.9%) after 3 hours ambulation. Four
patients had clinical signs of ultrafiltration failure. In 4 out of 6 patients,
maintenance of CAPD was impossible because of CAPD-related com-
plications: 3 patients, peritonitis; 1 patient, exit site infection and
leakage followed by removal of a catheter. Throughout the study
period, 2 out of 4 patients died after I month and 2 other patients were
transferred to hemodialysis. Of the 2 other remaining patients, one died
of a cerebrovascular accident during CAPD therapy and another had a
combination of hemodialysis and CAPD because of poor ultrafiltration.
We also observed 13 other patients, that in spite of recurrent peritonitis
episodes, PSG remained normal and the recovery of radioisotope from
peritoneal cavity was high (mean 72.3%). These patients could continue
CAPD for a longer duration, and therefore had a better outcome from
CAPD. In summary, multifocal distribution of radioactivity on PSG
reflects a poor prognosis of CAPD outcome.
Clinical course of hepatitis B and hepatitis C liver disease in renal
transplant recipients. S.A. Yoon, C.W. Vang, D.C. fin, S.f. Ahn, 1'S.
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Kim, Y.S. Yoon, and B.K. Bang, Department of internal Medicine,
Catholic University Medical College, Seoul, Korea. In order to evalu-
ate the impact of HBsAg and anti-HCV on renal transplantation, we
reviewed the incidence, kinetics and outcome of hepatitis in HB5Ag
positive patients and anti-HCV positive patients. From March 1985 to
March 1992, 68 patients (11.4%) were HBsAg positive in a total of 596
recipients and 7 of 68 HEsAg positive patients who were also anti-HCV
positive (10.3%). Ten patients were excluded because they had a
functioning graft less than 1 year or follow-up period was less than I
year. Hepatic dysfunction developed in 26 patients (44.8%) during the
follow-up period (mean 6.5 1.8 years). Among those with hepatic
dysfunction, 16 patients developed chronic hepatitis (27.6%), 9 devel-
oped intermittent elevation of liver enzyme (15.5%), and 2 developed
acute fulminating hepatitis (3.4%). Among those 16 with chronic
hepatitis, 2 patients progressed to fulminating course of hepatic failure,
and 3 patients progressed to livercirrhosis. There were 7 deaths (12.1%)
related to liver disease and 7 deaths (12.1%) unrelated to liver disease.
A total of 433 patients were screened for antibody to HCV by a second
generation ELISA before and after transplantation. Among them, 55
patients were anti-HCV positive (12.7%), and 7 of 55 anti-HCV positive
patients were also HBsAg positive (12.7%), Eight patients were ex-
cluded because the follow-up period was less than 1 year. Nineteen of
the 47 anti-HCV positive patients (40.4%) developed hepatitis during
the follow-up period. Among those with hepatic dysfunction, 6 patients
(12.8%) showed intermittent elevation of liver enzyme and 13 showed
chronic hepatitis (27.7%). In conclusion, there were similar incidences
of chronic hepatitis in both of HBsAg and anti-HCV positive patients,
but the clinical courses of hepatitis were less severe in anti-HCV
positive patients, so HCV infection does not clearly influence the
survival of allograft or that of kidney recipients. The present findings
suggest that asymptomatic patients with positive tests for HBsAg and
HCV should not be excluded from the renal transplantation program.
Effects of lILA matching on the graft survival of living kidney
transplantation in a single center. Y.S. Yoon, B.K. Bang, D.C. fin, S.A.
Yoon, Y.S. Kim, W.I. Kim, and Y.B. Koh, Department of Internal
Medicine, Department of Clinical Pathology, Department of General
Surgery, Catholic Medical Center, Seoul, Korea. Whereas all large
multicenter studies showed a beneficial HLA matching effect, some
single center studies have shown little improvement in graft survival
through matching. Our reports previously indicated that DR and B+DR
matching in the living donor kidney transplantation had a positive effect
on graft survivals. To confirm the effect of HLA matching on graft
survival in LRD and NRD grafts respectively, we analyzed 619 CsA-
treated primary LRD (N = 277) and NRD (N = 342) kidney transplants.
The 5-year kidney graft survival in the 0 and I HLA-DR mismatched
(MM) LRD was 78% and 79%, which was significantly different from
67% survival in the MM2 group (P = 0.0482). A significant effect of
HLA-DR matching on the 5-year graft survivals in the NRD group also
appeared (MMO: 86%, MM1; 75%, MM2; 45%, P = 0.0072). When B
and DR loci are combined, long-term effects were observed. At 5 years,
graft survivals were 84%, 79%, 76%, 67%, 100% in the LRD group,
respectively (P = 0.0200), and 85%, 92%, 72%, 70%, 62% in the NRD
group, respectively (P = 0.0518). However, the effect of A, B, A+B,
A+DR and A+B+DR mismatching grades in the LRD and NRD groups
showed little difference through matching numbers. In conclusion,
matching for the HLA-DR, B + DR has significantly improved long-term
graft survival in CsA-treated primary LRD and NRD kidney trans-
plants.
Lipoprotein(a) concentration in chronic renal failure and after renal
transplantation. C.W. Yang, S.f. Ahn, f.Y. Woo, Y.S. Kim, 5.1'. Kim,
E.f. Choi, Y.S. Chang, Y.S. Yoon, and B.K. Bang, Department of
Internal Medicine, Catholic University Medical College, Seoul, Korea.
Lp(a) is an independent risk factor of atherosclerotic vascular disease
and is known to be elevated in patients with chronic renal failure (CRF).
Therefore, this study was performed to evaluate the effect of kidney
transplantation (KT) on lipid profile and serum Lp(a) levels in 31 CRF
patients (M:F 25:6, age 37.0 11.5). The results are as follows: (I)
Lp(a) levels in CRF were elevated compared to controls (P < 0.01). (2)
The elevated Lp(a) levels in the pretransplant period were significantly
decreased one week after KT (P < 0.05), and these levels were not
changed significantly during 6 months follow-up. (3) Lp(a) levels were
not correlated with total cholesterol, triglyceride, LDL and HDL
levels.
Parameters Control Pre-KT
Lp(a) mg/dl 9.6 6.2 25.5 l9.2a
Chol mg/dl 146.8 28.8 164.0 47.8
TGmg/dl 131.9±42.1 158.6
HDL mg/dl 32.5 6.5 28.8 11.2
LDL mg/dl 88.0 37.2 99.7 47.8
LDL/HDL 2.9 1.5 3.6 1.7
Smg/dl 1.0±0.2 11.8±3.0
Parameters
Post-KT
I week 4 weeks 6 months
Lp(a) mg/dl 16.2 l2.S 12.8 93b 15.9 156b
Chol mg/dl 193.9 80.8 216.4 93.0 188.1 38.3
TG mg/dl 163.6 38.2 199.9 49.5 198.9 44.5
HDL mg/dl 33.6 10.9 49.1 19.4 52.5 20.1
LDL mg/dl 79.4 31.2 115.0 48.7 103.7 51.6
LDL/HDL 3.1 1.8 2.3 1.4 2.4 1.4
Scr mg/dl 1.3 0.3 1.3 0.3 1.3 0.3
Values are mean sn. a p < 0.01 vs. control; bP < 0.05 vs. pre-KT
Conclusion: The levels of Lp(a) were decreased after KT, which may be
in part associated with increased metabolism of Lp(a).
The significance of "Tc-DTPA GFR in early post-transplant period.
S.A. Yoon, Y.S. Yoon, Y.S.Shin, Y.S.Kim,B.K.Bang,andS.K.Jung,
Department of internal Medicine, Department of Radiology, Catholic
University Medical College, Seoul, Korea. Creatinine clearance (Car) is
most commonly used to evaluate renal function; however, the utility of
Ccr measurements is also limited by the necessity for collection of a
timed urine sample and by variability in serum creatinine levels and
measurements. To assess the significance of mTcDTPA as an index of
GFR, GFR estimated by mTcDTPA is compared with Cr and
predicted Cr ('Cr) estimated by the formula devised by Cockcroft
and Gault in 254 early (mean 9.3 3.1 days) renal transplants, from
August 1990 to January 1993. mTcDTPA GFR was closely correlated
to Cr (r = 0.50, P = 0.000) and PCcr (r = 0.48, P = 0.000). C. and
PCcr were significantly lower than 'mTc-DTPA GFR by 6.7 mI/mini
1.73 m2 (9.2%, P = 0.000) and 6.0 mllminil.73 m2 (8.2%, P = 0.000),
respectively. In conclusion: (1) S9mTcDTPA GFR was closely corre-
lated to Cr and PCr. (2) mean value of s9mTc DTPA GFR was 72.8
mI/mm/i .73 m2. (3) C. and PCr were lower than SSmTcDTPA GFR by
9.2% and 8.2%, respectively.
S9mTcDTpA
mI/mini] .73 m2
Ce,.
mi/mini] .73 m2
PCr
ml/min/1.73 m2
Means SD 72.8 24.9 66.1 23.7 66.8 21.2
r 0.50 0.48
P 0.000 0.000
% decrease 9.2 8.2
P 0.000 0.000
Proteinuria in renal transplant recipients: Incidence, cause and prog-
nostic importance. H.C. Kim, S.H. Lee, S.B. Park, and K.G. Park,
Department of Internal Medicine and Pathology, Keimyung University
Hospital, Taegu, Korea. The incidence, causes and prognostic impor-
tance of proteinuria after renal transplantation were evaluated in 204
patients who received a transplant from living donors at Keimyung
University Hospital between January 1983 and March 1993, in whom
graft function was achieved for at least 6 months, and in whom serial 24
hour urine protein excretion rates were avallable. One hundred fifteen
(56.4%) patients had no proteinuria, 32 (15.7%) patients had transient
proteinuna, and 57 (27.9%) had nontransient proteinuria. The most
frequent cause was acute rejection. The patients in the transient
proteinuna group experienced good graft outcome—namely, 100%
1-year, 90% 3-year, and 90% 5-year actuarial graft survivals, which was
similar to that observed in patients without proteinuria. In contrast, the
1, 3 and 5-year actuarial graft survivals in patients with nontransient
proteinuria were 92.5%, 66.3% and 30.8%, respectively, which are
significantly lower than those observed in patients without or transient
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proteinuria (P < 0.001). Forty-four of 57 patients with nontransient
proteinuria had renal biopsies, The causes of proteinuria in these 44
patients were as follows: transplant glomerulonephritis (18), chronic
rejection (11), transplant glomerulopathy (5), cyclosporine nephrotox-
icity (5), acute rejection (4), and hemolytic uremic syndrome (1). Of the
19 patients who developed transplant glomerulonephritis, 4 had recur-
rent (3 focal sclerosis and hyalinosis, 1 IgA nephropathy); in 15, the
type of glomerulonephritis could not be classified as recurrent or as de
novo, because of lack of characterization of the original kidney disease.
In follow-up, 43.9% of the patients with nontransient proteinuria
experienced graft loss within a mean time of 29.4 months. This study
suggests that the nontransient proteinuria in renal transplant recipient
predicts a poor graft outcome,
Use of granulocyte-macrophage colony stimulating factor (GM-CSF) in
azathioprine-mduced leukopenic renal transplant recipients. D.C. fin,
Y.S. Yoon, S. Y. Kim, E.J. Choi, and B.K. Bang, Department of
Internal Medicine Catholic University Medical College, Seoul, Korea.
Leukopenia often occurs in kidney transplant recipients who receive
azathioprine (Aza) as the immunosuppressive regimen. GM-CSF can be
used for early bone marrow recovery. We report the use of GM-CSF
(Lucky Biotec, Korea) in 9 cases of Aza-induced leukopenic renal
transplant recipients. Nine patients (8 male/i female, mean 36 years old,
mean post-transplant follow-up 36 months, mean Sr 2.9 mg/dl) re-
ceived Aza (mean 97.2 mg/day with PDN 13.3 mg/day) and developed
leukopenia to 1,380/mm3 of WBC count. These patients were adminis-
tered GM-CSF with 200—400 ig/day s.c. for 3 to 9 days after prompt
cessation of Aza.
Post-
GM- GM-
Scr Aza CSF CSF
Case
no. Sex
Age
years
PSKT
months
mg/ mg/dl day
PDN
mg
sg X
days
WBC
mm3
WBC
mnr
1 M 35 46 5.4 50 15 200 x 6 600 7,800
2 F 28 41 5.0 100 0 200 x 3 2,800 10,600
3 M 36 25 2.8 100 20 200 x 4 2,100 5,900
4 M 65 18 1.3 100 0 400 x 8 800 6,500
5 M 37 7 5.5 100 10 400 x 9 1,800 10,400
6 M 37 10 2.2 100 20 400 x 2 1,300 6,300
7 M 33 2 1.9 100 15 400 x 3 1,700 8,400
8 M 31 1 2.5 125 30 200 x 7 700 16,800
9 M 22 13 2.4 100 10 400 x 8 600 7,900
Mean 36 36 2.9 97.2 13.3 200400
x 5.6
1,380 8,956
In conclusion, GM-CSF can be useful for early bone marrow recovery
in leukopenic renal transplant recipients.
Ten cases of malignancies in allograft kidney transplants. D.C. fin,
V.5. Yoon, S.A. Yoon, V.5. Kim, B.K. Bang, and Y.B. Koh, Depart-
ments of Internal Medicine and General Surgery, Catholic University
Medical College, Seoul, Korea. The marked increment of malignancy
incidences after allograft transplantation (up to 100 times higher than in
the general population) must be recognized. We diagnosed 10 cases
(1.2%) of malignancies among the 820 renal transplant recipients from
1969 to the end of 1992 in the Catholic Medical Center. Seven men and
two women recipients were diagnosed as four stomach cancers, two
malignant lymphomas, one cervix cancer, one Wilms' tumor, one large
cell lung cancer, and one skin cancer. The duration from transplantation
to diagnosis was 6 to 169 months (median 52 months). Three cases were
managed with Aza and PDN, 5 cases with CsA and PDN, and 1 case
with triple regimen. The therapeutic results were five living with
functioning grafts, and five deaths (one death caused by uremia and four
deaths associated with malignancy).
Interval
between
Case
No.
Age/
Sex
KT and
Dx
months
Immuno-
suppressant Diagnosis
Last
Cr
mg/dl Outcome
1 34/M 169 Aza/PDN stomach ca 3.9 death
2 48/M 76 Aza/PDN stomach ca 1.4 death
3 52/M 154 AzaIPDN skin ca 9.0 death
4 46/M 52 CsAIAzaJ
PDN
lung ca 1.4 alive
5 47/F 21 CsA/PDN Wilms' tumor 1.1 alive
6 31/F 25 CsA/PDN cervix ca 1.6 alive
7 48/M 21 CsA/PDN stomach ca 1.3 death
8 52/M 6 CsA/PDN/
OKT3
lymphoma 1.4 alive
9 32/F 6 CsA/PDN lymphoma 2.7 death
10 49/M 84 CsA/PDN stomach ca 2.5 alive
Median 48 years 52 1.6
In conclusion, 10 cases (1.2%) of malignancies after kidney transplan-
tation were characterized as (1) most common cancer: stomach cancer;
(2) post-transplant duration: 52 months; (3) five living with functioning
graft and five deaths.
